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Introduction 1
1 Introduction 
 
Peptides are amino acid polymers in which the individual amino acids are connected by 
amide linkages from the carboxyl group of one unit to the amino group of another. 
Peptides have the most diverse functions. Their diverse nature encompasses sweeteners, 
toxins, antibiotics as well as growth factors. Peptides can also act as stimulators and 
inhibitors of hormone release. Over 200 new peptide based drugs are under different 
stages of development with 50% of them under clinical trials are prior to approval 
(Marder and Albericio, 2003). Due to the importance of peptides, it has become a 
challenge for synthetic chemists to develop methodologies to construct peptides over the 
past few decades. 
 
The synthesis of the first simple peptide derivatives by Curtius (1881) and then by 
Fischer and Fourneau (1901) marked the beginning of the peptide synthesis. The 
difficulties experienced in the synthesis of simple peptides stimulated a continuous effort 
toward improvements in the methodology of peptide synthesis. Introduction of the easily 
removable amino protecting benzyloxycarbonyl group (Bergmann and Zervas, 1932) was 
a major breakthrough in the field of peptide synthesis. The isolation of oxytocin in pure 
form (Pierce et al., 1952), the determination of its structure (du Vigneaud et al., 1953a; 
Tuppy, 1953) and its total synthesis (du Vigneaud et al., 1953b) gave a great impetus to 
the development of synthetic procedures. The introduction of dicyclohexylcarbodiimide, 
a still unsurpassed coupling reagent (Sheehan and Hess, 1955) had a major impact on the 
methodology of peptide bond formation and further refinement was brought about by the 
development of active esters (Schwyzer, 1953; Bodanszky, 1955). Long series of 
blocking groups which are cleaved under mild conditions were developed. Especially 
valuable are the tertiary butyloxycarbonyl (Boc) group (Carpino, 1957) and 9-
fluorenylmethyloxycarbonyl (Fmoc) group (Carpino and Han, 1970) which are acid and 
base labile respectively. Originally all synthetic peptides were routinely prepared by 
conventional solution methods that is, both reactants were soluble in the reaction media. 
The invention of solid phase peptide synthesis (Merrifield, 1963) has simplified the 
operational procedures and opened the prospect of fully automated synthesis. 
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As a consequence of van’t Hoff’s concept of the equilibrium constant in a reversible 
chemical reaction (van’t Hoff, 1898), it was concluded about 110 years ago that the 
hydrolytic action of enzymes should be reversible and the formation of the peptide bond 
should also be possible.  
 
In 1938, Bergmann’s group reported the first enzymatic synthesis of a defined peptide 
(Bergmann and Fraenkel-Conrat, 1938). Today the use of enzymes in peptide synthesis 
plays a promising role as a complement to the chemical method, in synthesizing peptides 
for research, clinical, and industrial interest (Mccoy, 2004).          
  
The general condensation reaction of the peptide synthesis describes the connection of 
amino acids with the removal of water which is outlined in scheme 1.1. 
 
CHNH2
R1
COOH + CHNH2 COOH
R2
NH2 CH
R1
CO NH CH
R2
COOH H2O+
 
Scheme 1.1 Basic principle of peptide synthesis. R1 and R2 = side chain functionalities. 
 
1.1 Chemical peptide synthesis 
Chemical peptide synthesis takes place via three major steps which are described as 
follows. 
 
(1) First step 
As the amino acid contains at least two functional groups, the carboxyl component and 
the amino component of the non reacting end have to be protected. If the side chain has a 
reactive functional group, then it also needs to be protected. In synthesis of a larger 
peptide, a careful planning is required to match the coupling methods and protecting 
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groups. The most important protecting groups applied in chemical peptide synthesis are 
described as follows. 
 
Amino protecting groups 
Cbo or Z group. The benzyloxycarbonyl group (Bergmann and Zervas, 1932) is an 
important amino protecting group which smoothly undergoes homolytic fission on 
catalytic hydrogenation. The process of hydrogenation is generally carried out in 
presence of a palladium catalyst deposited on charcoal. Other methods, for instance 
reduction with sodium in liquid ammonia (Sifferd and du Vigneaud, 1935) and acidolysis 
(Ben Ishai and Berger, 1952), particularly by HBr in acetic acid are also used. 
 
Boc group. The tert. butyloxycarbonyl group was introduced by Carpino (1957). The Boc 
group is similar to the Cbo group but the benzyl group is replaced by the tert. butyl 
group. The +I inductive effect of the three methyl groups of the Boc group gives rise to a 
stable cation, hence in contrast to the Cbo group, the Boc group can be easily cleaved by 
trifluoroacetic acid. 
 
Fmoc group. The 9-fluorenylmethyloxycarbonyl group was introduced by Carpino and 
Han (1970). This group is removed from the amino group by proton abstraction with 
secondary amines. Piperidine and diethylamine are the recommended bases. 
 
Carboxyl protecting groups 
The general approach for carboxyl protection is esterification. 
 
Methyl ester and ethyl ester. These esters are readily available through esterification, that 
is, by the introduction of HCl into an alcoholic suspension of the amino acid (Curtius and 
Goebel, 1888) or by the addition of the amino acid to a cold mixture of thionylchloride 
and methanol or ethanol (Brenner and Huber, 1953). Generally, methyl and ethyl esters 
are good blocking groups, because they can be cleaved easily by alkaline hydrolysis.  
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tert. Butyl ester. The tert. butyl ester is prepared by the addition of isobutene to the 
carboxyl group (Roeske, 1959) or transesterification of carboxylic acid esters with 
tert.butyl acetate (Taschner et al., 1961). It is generally resistant against nucleophilic 
attack, base catalyzed hydrolysis and weak acids. However, the tert. butyl group is 
removed with moderately strong acids, such as diluted solutions of HCl in acetic acid or 
trifluoroacetic acid in dichloromethane. 
 
(2) Second step 
Formation of an amide bond between two amino acids is an energy-requiring reaction. In 
order to avoid high temperature to form a peptide bond, either the carboxyl or the amino 
group must be activated. So far, no practical activation of the amino group has been 
found. The usual approach is activation of the carboxyl group, that is, the hydroxyl group 
of the carboxyl group is replaced by an electron withdrawing substituent (X). The X 
group can enhance the polarization of the carbonyl group and thereby the electrophilicity 
of its carbon atom. Thus, the nucleophilic attack by the amino group is greatly enhanced. 
The peptide bond is formed by coupling the carboxyl component and the amino 
component via an α-amide linkage. The most important practical coupling methods are 
specified below. 
 
Azide method. The activation in the form of acid azides (Curtius 1902) remains even 
today an important and practical approach for the synthesis of peptides. Hydrazinolysis of 
alkyl esters and then conversion of hydrazides to acid azides with the help of nitrous acid 
or alkyl nitrites are still practiced for the activation. The direct conversion of carboxylic 
acids to acid azides with the help of diphenylphosphorylazide has become an alternative 
way in recent years. This method is important because there is negligible racemization 
and therefore it can be used for fragment condensation. The major drawback of this 
method is the Curtius rearrangement of acid azides to isocyanates. 
 
Anhydride method. The treatment of amines with anhydrides of carboxylic acids leads to 
acylation. Reacting a symmetric anhydride of a peptide or an N-protected amino acid 
with the amino component of an amino acid or peptide would result in the loss of half of 
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the carboxylic unit of the anhydride because only half of it is used for peptide bond 
formation as shown in following reaction. 
 
                     R-CO-O-CO-R + H2N-R’                       R-CO-NH-R’ + RCOOH 
 
Therefore, certain unsymmetrical anhydrides which react with the amino component only 
at the carbonyl of the N-protected aminoacyl component are used (Chantrenne, 1947). 
The reaction of the amino component only at a particular carbonyl group takes place 
because of the difference of electrophilic character between two carbonyl groups. The 
reaction of the unsymmetrical anhydride with an amino component is given below where 
Y is the amino protecting group. 
 
                            Y-NH-CHR-CO-O-CO-C(Me)3 + H2NR’  
 
 
                        Y-NH-CHR-CO-NHR’+ (Me)3C-CO-NHR’ + (Me)3C-COOH 
                                                                           (traces) 
Carbodiimide method. This method was introduced by Sheehan and Hess (1955). The 
coupling reagent, dicyclohexylcarbodiimide (DCC) is added to the mixture of the 
carboxyl component and the amino component. Thus, activation and coupling proceed 
concurrently. Amines also react with carbodiimide but the rate of this reaction is 
negligible, when compared with the rapid rate observed in the addition of carboxylic 
acids to one of the double bonds of a carbodiimide. Addition of carboxylic acid to 
carbodiimide results in the formation of O-acyl isoureas as an intermediate. The N=C 
group in O-acyl-isoureas provides activation which leads to coupling. The insoluble by-
product, N, N’-dicyclohexylurea (DCU) formed in this reaction can be removed easily by 
filtration. In some cases, both racemization and N-acyl urea formation takes place. Both 
of them can be suppressed to some extent by the addition of auxiliary nucleophiles such 
as 1-hydroxybenzotriazole (HOBt) as proposed by König and Geiger (1970). 
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Active ester method. The carboxyl group is activated by the formation of an active ester 
in which an electron withdrawing group is present. The exclusive application of p-
nitrophenyl esters for the synthesis of oxytocin (Bodanszky and du Vigneaud, 1959) 
demonstrates that active esters are particularly well suited for the stepwise elongation of a 
peptide chain by the addition of single amino acid residues. 
 
(3) Third step 
After the synthesis is complete, the protecting groups must be totally removed in order to 
release the free target peptide. If the synthesis is to be continued, temporary protecting 
groups must be removed prior to each elongation step of the growing peptide chain. 
 
1.1.1 Classical peptide synthesis 
Both reacting components are mixed in homogenous solution. After each coupling step, 
the purification of the product is done, generally through crystallization or 
chromatographic methods. 
 
1.1.2 Solid phase peptide synthesis 
This method was introduced by Merrifield (1963). The basic plan is illustrated in Scheme 
1.2. An amino acid with protected amino group is bound covalently to a synthetic 
polymer that bears reactive groups (X) (e.g. chloromethylated polystyrene).  Peptide bond 
formations are carried out by repeating deprotection and coupling step. The peptide of the 
desired sequence is assembled on the polymer support. Finally, the peptide is cleaved 
from the support with the appropriate reagent.  
 
Introduction 7
 
 
Scheme 1.2 Reaction scheme of the solid phase peptide synthesis. Y= α-amino protecting              
                    group; X= reactive group; P= polymer. 
 
The essential advantage of using a solid support is that all the laborious purifications at 
intermediate steps in the synthesis are eliminated. Only filtration and washing procedures 
are necessary and automatization is easy. However, one of the major disadvantages of the 
solid phase synthesis is the occurrence of failure and truncated sequences, if the yield of 
every coupling step is less than 100% (Bayer et al., 1970). 
 
 
 
 
 
X 
+ DCC 
Deprotection Coupling 
Loading the amino acid 
Cleavage 
Peptide 
X 
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1.2 Enzymatic peptide synthesis 
During the chemical peptide synthesis, the limitations arise mainly from the many 
possible side reactions (Bodanszky et al., 1979; Bodanszky and Martinez, 1981). 
Racemization has been a major problem in the chemical peptide synthesis throughout its 
history. To circumvent these problems, an increasing number of peptide syntheses are 
conducted under the catalysis of enzymes (Jakubke et al., 1985; Isowa et al., 1979; 
Jakubke et al., 1996). 
 
1.2.1 Enzymes 
In order to achieve the high reaction rates observed in living organisms, enzymes are 
required to lower the activation energy of the reaction. Some enzymes are purely protein. 
In other cases, the functional enzyme consists of two parts, collectively called a 
holoenzyme, an apoenzyme (the protein portion) and a cofactor. Depending on the 
enzyme, the cofactor may be an ion of a metal such as copper, iron, zinc or an organic 
molecule needed to assist the reaction in some particular way. 
 
In the first step, an enzyme must come into contact with reactants, which are called 
substrates in the case of enzyme–mediated reactions. The enzyme combines with the 
substrate to form an enzyme substrate complex, which breaks down to release products 
and enzymes. The reaction between enzyme and substrate can be written as  
 
     S      +      E                                 ES            P        +         E 
Substrate Enzyme         Enzyme-Substrate            Product     Enzyme 
                                                             complex 
 
At the end of the reaction, the enzyme is free to undergo the same reaction with 
additional substrate molecules. The overall effect is to accelerate the conversion of a 
substrate into the product, the enzyme acting as a catalyst. The region of the enzyme, to 
which the substrate binds, is known as the enzyme’s active site. Each enzyme is highly 
specific. On the basis of the catalyzed reactions, enzymes can be classified into 
oxidoreductases, transferases, hydrolases, lyases, isomerases and ligases. Among them, 
hydrolases have been the subject of more intensive study than any other. 
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(1) Proteases 
Proteases are those sorts of hydrolases, which cleave peptides within their chain into 
smaller peptide chains (endoproteases) or hydrolyze peptides from the end to release 
single amino acids at each reaction cycle (exoproteases). The reversal of the proteolytic 
cleavage of the peptide bond by proteases leads to the enzymatic peptide synthesis. The 
shorthand notation of the specificity of protease, proposed by Schechter and Berger is 
represented in Scheme 1.3. According to this model, peptides undergoing cleavage are 
designated P1, P2, P3 etc. in the N-terminal direction from the cleaved bond. Likewise, the 
residues in C-terminal direction are designated P1’, P2’, P3’ etc. In the same way, active 
site of the protease is named as S1, S2 or S1’, S2’ corresponding to P1, P2 or P1’, P2’ of 
peptide respectively. 
           
Scheme 1.3 Schematic representation of substrate-protease interactions (Schechter and       
                     Berger, 1967).  
 
There are four main types of endoproteases. 
Serin proteases (e.g. Chymotrypsin, Trypsin, Elastase). They are characterized by a 
highly reactive serine residue in the active site. In the covalent substrate enzyme 
complex, an acyl ester is formed between the carboxylic acid of the bond being split and 
the serin hydroxyl function. 
 
α–Chymotrypsin. It hydrolyzes amides and esters as well as peptides and shows a marked 
preference for links involving aromatic amino acid residues, such as phenylalanine, 
tyrosine or tryptophan (P1 site) (Bergmann and Fruton, 1937; 1938). The primary 
specificity of α-chymotrypsin, which is definitely associated with the P1 position, may be 
extended, if the esterase activity of the enzyme is also considered (Kloss and Schröder, 
Splitting site 
H2N 
S1’ S2’ S3’ S3 S2 S1 
P1’ P2’ P3’ P3 P2 P1 COOH 
Protease 
Peptide 
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1964). The secondary specificity of the enzyme is expressed to a minor degree, so that 
there exists a certain preference for hydrophobic amino acid residues in the P2 and P1’ 
position of the chymotryptic substrates (Bauer, 1978).                     
 
Trypsin. It is also a serin endopeptidase whose action is strictly confined to peptide 
linakge, the carbonyl group of which is contributed by a basic amino acid such as lysine 
or arginine (Keil, 1971). The aspartate residue located in the catalytic pocket (S1) of 
trypsin is responsible for attacking and stabilizing positively charged lysine or arginine. 
Trypsin catalyzed peptide synthesis proceeds under kinetic control and trypsin have an 
optimal operating pH of about 8 and optimal operating temperature of about 50° C. 
 
Cysteine protease (e.g. Papain, Ficin). The catalytic mechanism involves a thioester 
linkage with the carbonyl moiety of the peptide bond and the side-chain of a cysteine in 
the active-site. 
 
Papain. Papain is isolated from Carica papaya. It displays rather broad substrate 
specificity, but nevertheless, it exhibits a preference for bulky hydrophobic amino acid 
residues in the P2 position of a given substrate (Fruton, 1982). Thus, the P1 site of the 
substrate, associated with the secondary specificity of papain, can be occupied by a 
variety of amino acids (Brubacher and Zaher, 1979). Due to the structural stability of 
papain over a wide pH range, papain-controlled peptide synthesis has been performed 
within a broad pH spectrum, which ranges from 4.7 (Milne et al., 1957) to 9.5 (Mitin et 
al., 1984). 
    
Acid proteases (e.g. Pepsin, Chymosin). The active site of acid proteases relies on two 
acidic aspartate amino acids. The acid proteases have the pH optimum in the low acid 
range. 
 
Metalloproteases (e.g. Thermolysin). They possess metal ions in the active centre. An 
example is thermolysin, which is mainly used in thermodynamically controlled reactions. 
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Thermolysin. The neutral metalloprotease, isolated from Bacillus thermoproteolyticus 
has frequently been used in enzymatic peptide synthesis. The enzyme binds one zinc ion 
which is essential for catalytic activity and four calcium ions which are required for its 
thermostability. Thermolysin exhibits a strong preference for peptide bonds, in which P1’ 
is a bulky hydrophobic amino acid residue except in the case of tryptophan. Because of 
its stability at elevated temperature, the reactions can be catalyzed at higher temperature 
with increased solubility of the educts. 
 
(2) Amidases 
One of the sub-groups of hydrolases comprises a number of enzymes hydrolysing –CO-
NH- links which are not concerned with protein breakdown. 
 
Penicillin G Amidase (PGA). The enzyme from Escherichia coli cleaves not only the 
phenylacetyl group of benzylpenicillin (Penicillin G), but also a variety of substituted and 
unsubstituted phenylacetamides that are not related to benzylpencillin (Margolin et al., 
1980). The S1-subsite specificity of PGA is mainly restricted to phenylacetic acid and its 
derivatives (Virden, 1990). The exploitation of the hydrolytic potential of amidases other 
than proteases for the enzymatic removal of Nα-blocking groups in peptide synthesis has 
the advantage that it does not cleave peptide bonds. In this connection, Widmer et al., 
(1983) and Brtnik et al., (1981) suggested the use of PGA as a catalyst for Nα-
deprotecting steps. 
 
1.2.2 Enzyme immobilization 
Here, immobilization is understood as the attachment of enzymes on insoluble support 
materials mostly polymers. Since enzymes are sometimes not stable in the presence of 
high concentrations of organic solvents or in the presence of hydrophobic interfaces of 
nonmiscible solvents (Kasche et al., 1987), immobilization can be used to reduce enzyme 
denaturation. Because immobilized enzyme molecules are not able to autolyze and 
aggregate due to full dispersion, immobilized enzymes show better stability than that of 
the free enzymes (Klibanov, 1979; Capellas et al., 1996a; 1996b). 
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Besides the higher stability, the immobilisates have many other advantages, e.g. the 
reaction can be performed continuously in a reactor and controlled easily (Eckstein and 
Renner, 1995). Repeated use of the immobilisates might be important from the view of 
economy, especially in industrial processes. The immobilized enzymes can be easily and 
completely separated from the reaction system and do not contaminate the synthesized 
peptides, which is of importance in case of pharmaceutical use of peptides. The 
immobilized enzyme can be recovered by a simple filtration step. 
 
There are several methods for the immobilization of enzymes. 
• By inclusion using gel or membrane 
• By adsorption on ion exchangers 
• By deposition onto solid materials (e.g. Celite) 
• By chemical covalent bonds on polymers. It can take place either by cross-linking 
reaction of the enzymes or by preferentially binding the enzymes onto the outer shell 
of modified carrier materials with preselected properties (Horvath and Engasser, 
1973). 
 
1.2.3 Advantages of the enzymatic peptide synthesis 
The most obvious advantage of enzymatic synthesis results from one of the most 
impressive biological phenomena, namely, the pronounced capacity of an enzyme to 
catalyze chemical reactions with an otherwise unattainable specificity.  
 
Proteases usually demonstrate an absolute preference for the L-enantiomeric form of an 
amino acid residue. Hence, the enzymatically catalyzed peptide bond formation results in 
an optically pure product, even if the starting material might have been contaminated 
with some D-enantiomer.  
 
The proteases are only associated with the α-carboxyl and the α-amino group of the 
sensitive peptide bonds. Therefore, in a protease catalyzed reaction, generally the side 
chains and other functional groups are not needed to be protected in contrast to the 
chemical peptide synthesis. 
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In addition, enzymatic peptide synthesis can be achieved under mild conditions with 
commercially available proteases which are easy to handle and, due to their application in 
catalytic amounts only, the costs are mostly insignificantly higher in comparison with 
chemical coupling reagents. By avoiding hazardous chemicals and less critical reaction 
steps, this method is a good example of “green chemistry”. A very good example is the 
synthesis of aspartame on a large scale in industry, starting from L-Cbo-Asp-OH and D, 
L-Phe-OMe (Isowa et al., 1979). 
 
1.2.4 Methods of enzymatic peptide synthesis 
The enzyme-catalyzed peptide bond formation can be divided into two approaches 
namely thermodynamic and kinetic approaches. 
 
1.2.4.1 Thermodynamically controlled peptide synthesis  
In this approach, peptide bond forms by the free carboxyl terminus which is a direct 
reversion of the protein hydrolysis. This is illustarted in scheme 1.4 
 
                                 
K syn
R CO NH R1 + H2OR COOH
R COO
-
+
+ NH2 R1
NH3
+
R1
K
1 K2
 
  
 
 
 
 
 
 
. Scheme 1.4 Thermodynamically controlled peptide bond formation. R = acyl residue of 
                      the carboxyl component; R1 = residue of the amino component; x = relative  
                      concentration (%); t = time. 
 
 
R-CO-NH-R1 
t 
R-COOH 
x 
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           It has to be noticed that only non-ionized substrates (amino acids or peptides) participate 
in the peptide bond formation (Linderstrom–Lang (1962) and Carpenter (1960)). In 
practice, due to the amphoteric nature of the amino acid or peptide, they are ionized over 
the entire pH range. They can behave either as cations in an acidic environment or as 
anions in a basic environment. Thus, the predominant contribution to the energetic barrier 
to proteosynthesis is accounted for by ionization-neutralization effects. There are two 
ways to shift equilibrium towards the desired peptide coupling: 
 
(1) Shift of ionic equilibria 
The main obstacle to peptide bond synthesis, which comes in the form of the energy 
required for the proton transfer, depends crucially on the ionization equilibria of the 
reactants. An increase of the pK1 value and/or a decrease of the pK2 value of a given pair 
of educts, will reduce the energy consumption of the proton transfer and will, as a result, 
cause the equilibrium shift in favour of peptide synthesis. 
 
Cancelling the zwitterionic character of the reactants. The highly endergonic characters 
of the proton transfer can be accounted for by the strong acidity and basicity of the α-
carboxyl and α-amino groups of the reactants which in turn, can be attributed to the 
zwitterionic nature of free amino acids and peptides. Consequently, a favourable pK shift 
of the ionogenic groups may be achieved by curtailing the zwitterionic character of the 
respective educts. This can be readily done by the introduction of α-amino and α-
carboxyl protecting groups, a procedure which is routinely used in peptide synthesis. 
 
Effects of organic co-solvents. Another technique to shift ionic equilibria in favour of 
peptide synthesis is to add organic solvents to the reaction mixture. By lowering the 
dielectric constant of the reaction medium, the organic co-solvent diminishes the 
hydration of ionic groups. This effect predominantly affects the pK value of those groups 
whose ionization represents a separation of charge (Michaelis and Mizutani, 1925), most 
notably carboxyl functions. Thus, the acidity of the α-carboxyl group and to a lesser 
extent, the basicity of the α-amino group can be reduced (Mizutani, 1925; Homandberg et 
al., 1978). 
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(2) Shift of chemical equilibria  
 
Solubility-controlled synthesis. This technique is based on the removal of the newly 
generated products from equilibrium by precipitation (Bergmann and Fraenkel, 1938; 
Bergmann and Fruton, 1938)) or selective extraction in a biphasic system (Basso et al., 
2000; Semenov et al., 1981).  
 
Effects of concentration. According to the law of mass action, the unfavourable 
equilibrium can be shifted towards synthesis by the means of the highest possible 
concentrations of the educts, especially of the amino component or by the means of using 
organic co-solvents to reduce the water concentration (Calvet et al., 1996). 
 
Temperature-dependent equilibrium shifts. The endothermic process of peptide bond 
formation (Borsook, 1953) will be enhanced with rising temperature, as governed by the 
Le Chatelier’s principle. 
 
1.2.4.2 Kinetically controlled peptide synthesis 
In the kinetic approach the carboxyl component is employed in an activated form, mainly 
as an ester derivative, and the synthesis occurs under kinetic control. The rapidly formed 
acyl enzyme intermediate can transfer the acyl moiety either in an aminolysis reaction to 
the added amino component forming the desired peptide product (R-CO-NHR1), or in a 
hydrolysis step with water forming R-CO-OH (Scheme 1.5). 
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Scheme 1.5 Kinetically controlled peptide bond formation. R= acyl residue of the  
                    carboxyl component; R1= residue of the amino component; H-E= protease; 
                    X= ester (leaving group); x= relative concentration (%); t= time. 
 
The optimal peptide yield depends on both the concentration and reactivity of the 
nucleophile as well as the rate of hydrolysis of the acyl-enzyme. Hence, it is important to 
favour the synthesis of the peptide bond by working at high concentration of the 
nucleophile and at low water concentration to minimize the proteolytic activity. As 
shown in scheme 1.5, the concentration of the product RCONHR1 is at its maximum at a 
particular time. The reaction has to be stopped at the “kinetic” optimum. It means if the 
reaction is terminated well before the equilibrium is established, the products which 
accumulate are those that are produced most rapidly. The progress of the reaction has to 
be controlled preferably by HPLC. 
 
R-COX 
R-CO-NH-R1 
R-COOH 
x 
t 
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2 General 
 
2.1 State of the art 
Cholecystokinin (CCK) is a polypeptide hormone of 33 amino acid residues with a key 
role in biological processes involved in the food absorption and digestion (Kissileff et al., 
1981; Schwartz et al., 1991). It can stimulate extensively the liberation of insulin and 
glucagons from the Langerhans islets (Verspohl et al., 1986). Besides these, it is a very 
important neurotransmitter as well (Tirassa et al., 2005). Full activity is retained in the C-
terminal cholecystokinin octapeptide (CCK-8), which is used to treat intestinal paralysis 
and is also a potential drug candidate for the treatment of type 2 diabetes (Ahren et al., 
2000), obesity (Volkoff et al., 2005) and epilepsy (Tirassa et al., 2005). 
 
The syntheses of biologically active peptides have been widely investigated because the 
market of peptides is continuously growing, especially in the food and pharmaceutical 
industries (Vivien, 2005).  
 
Cholecystokinin-8 (CCK26-33) has the amino acid sequence as given below 
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                         (H-Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2)  
 
Many efforts have been devoted to the synthesis of CCK-8, its derivatives and analogues 
(Ondetti et al., 1970; Toth et al., 1985; Penke and Rivier, 1987). Among the different 
methods, enzymatic peptide synthesis is investigated by several groups as an important 
complement to the chemical approach. The chemical synthesis of CCK-8 is difficult 
because it contains many functional amino acids prone to side reaction. 
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In 1982, Kullmann (1982) reported the first preparation of CCK-8 using enzymatic 
peptide bond formation as far as possible. The octapeptide was finally assembled by the 
chemical condensation of two tetrapeptide segments which have been synthesized 
through the concerted actions of several proteases of different specificity, namely by 
papain-, thermolysin- and α-chymotrypsin catalysis. The design of the synthetic strategy 
is outlined in scheme 2.1 and in an abbreviated form it can be described as [(2 + 2) + 4]. 
Boc-groups were employed as N-α protecting groups for all acyl-donors. The results of 
these preliminary studies indicated that fragments containing more than four amino units 
were not attainable exclusively by enzymatic means. Protecting groups applied in this 
scheme are those of the chemical synthetic strategy. 
 
 
 
Scheme 2.1 Synthesis of the C-terminal octapeptide amide of CCK-8 (Kullmann, 1982);          
                     -N2H2Ph = phenylhydrazide. 
 
 
Asp Tyr Met Gly Trp Met Asp Phe
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OBzl
OH
Thermolysin
Boc
OBzl
N2H2Ph
TFA
OBzl
N2H2PhHBoc OMe
Chymotrypsin
Boc N2H2Ph
1. Bromosuccinimide 
2. Ammonia
Boc NH2
OBzl
OBzl
TFA
H NH2Boc OH
Papain
Boc
OBzl
OBzl
NH2
TFA
NH2H
Papain
1. Bromosuccinimide 
2. EtOH
Boc
OBzl
OH H N2H2Ph
Boc
OBzl
N2H2Ph
Boc
OBzl
OEt
Boc OMe H N2H2Ph
Papain
Boc N2H2Ph
TFA
N2H2PhH
Chymotrypsin
N2H2PhBoc
OBzl
FeCl3
Boc OH
HOBt/DCC
NH2
OBzl OBzl
Boc
1.     /Pd, C
2.       SO3.
3. TFA
H NH2
OBzl OBzl
SO H3
N
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Another scheme to synthesize CCK-8 was presented by Sakina et al., (1988) in which a 
pentapeptide synthesized from dipeptide and tripeptide was coupled with a tripeptide. In 
an abbreviated form it can be written as [(2 + 3) + 3]. In this procedure, N-α protecting 
groups of acyl donors were Fmoc, Boc and Z which could be cleaved only by chemical 
way. The tripeptides (Met-Gly + Trp and Met + Asp-Phe) were also synthesized 
chemically. The detail procedure is outlined in the scheme 2.2 
 
Asp Tyr Met Gly Trp Met Asp Phe
Z
OBzl
OH H NH2
1. Np  2. H /Pd2
H NH2Boc OH
1. Tcp  2. 3NHCl
NH2. HClH
Boc OH H OH
Tcp
Boc OH H OMe
1.HOBt/DCC  
2. 3N HCl
H OMe . HCl
Fmoc OH H OMe
Thermolysin
Fmoc OMe
Chymotrypsin
Fmoc OH
1.Pyridinium 
trifluoroacetylsulfate 
2. Ba(OH)
Fmoc OH
SO Ba3 1/2
Thermolysin
Fmoc OMe
Papain
Fmoc
SO Ba3 1/2
NH2
H
Piperidine
SO Ba3 1/2
SO H3
NH2
Piperidine
 
 
Scheme 2.2 Synthesis of the C-terminal octapeptide amide of cholecystokinin (CCK-8)     
                     (Sakina et al., 1988). Np = p-Nitrophenol; Tcp = 2, 4, 6-trichlorophenol. 
 
Cerovsky et al., (1988) described another pathway to synthesize CCC-8 by [2 + (3 + 3)] 
fragment condensation. In this scheme, both tripeptides were synthesized chemically. The 
reaction between Boc-Met-Gly-Trp-OMe and H-Met-Asp-Phe-NH2 with α-chymotrypsin 
did not yield a satisfactory result because of the hydrolysis of α methyl ester of Boc-Met-
Gly-Trp-OMe. In this scheme also, protecting groups are those of the chemical synthetic 
strategy. The detail scheme is presented in scheme 2.3 
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Scheme 2.3 Synthesis of the C-terminal octapeptide amide of cholecystokinin (CCK-8) 
                     (Cerovsky et al., 1988). Pfp = pentaflurophenol; Tcp = 2, 4, 6-                                                      
                     trichlorophenol. 
 
Later on different fragments of CCK-8 were reported to be synthesized by enzymatic 
way. Capellas et al., (1996a) reported the enzymatic synthesis of the tripeptide derivative 
Z-Gly-Trp-Met-OEt. The effects of organic solvent, acyl–donor ester structure, the C-α 
protecting group of nucleophile, enzyme and substrate concentration were studied. 
 
The kinetically controlled condensation of Z-Gly-Trp-OMe and H-Met-OEt catalyzed by 
α-chymotrypsin in organic media was reported. The influence of water activity and the 
support material used to adsorb α-chymotrypsin on both product yield and enzymatic 
activity was investigated (Capellas et al., 1996b). 
 
The kinetically controlled condensation reaction of Z-Gly-Trp-Met-OX (X = Et, Al, 
Cam) and H- Asp(OR)-Phe-NH2 (R = H, tert. butyl) catalyzed by α-chymotrypsin 
deposited onto polyamide in organic media was studied (Capellas et al., 1997). Substrate 
concentration, reaction medium, acyl donor, nucleophile structure on both enzymatic 
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activity and pentapeptide yield was investigated. Cam ester was found to be the best acyl-
donor. The highest yield was obtained in acetonitrile as solvent. 
 
Calvet et al., (1996) synthesized all the dipeptide fragments of CCK-8 enzymatically and 
the reactions conditions were optimized. The best enzyme for each dipeptide synthesis 
was: papain, Asp-Tyr and Gly-Trp; α-chymotrypsin, Trp-Met and Met-Gly; thermolysin, 
Asp-Phe and Asp-Tyr; papain and α-chymotrypsin, Trp-Met and Met-Asp. 
 
Taking into account the information gained in previous fragment synthesis, Fite et al., 
(2002) described the total enzymatic synthesis of CCK-8. The Phac group was taken as 
N- α protecting group. The strategy for synthesis of Phac-CCK-8 is outlined in scheme 
2.4 which can be summarized as [3 + (3 + 2)] condensation. In this paper, it is not 
mentioned whether the Phac group can be cleaved from the protected CCK-8. 
 
Asp Tyr Met Gly Trp Met Asp Phe
Z OH H NH2
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Scheme 2.4 Synthesis of Phac-CCK-8 (Fite et al., 2002). 
 
The main disadvantage drawn from the above schemes is the limited use of enzymes. 
Many reactions were not feasible during enzymatic synthesis and sometimes the yields 
were very poor. Clape’s group could improve the enzymatic pathways of CCK-8 
synthesis but the Z- group had to be cleaved chemically. The Z- group is not suitable for 
chemical deprotection because the sulfhydryl group of methionine poisons the catalyst 
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during catalytic hydrogenation. Boc is also not suitable as it gives a stable carbocation 
during deprotection which can attack the indole ring of tryptophan. Therefore, there is a 
need for an alternative N- α protecting group, which can be cleaved enzymatically.  
 
Widmer et al., (1981) proposed the enzymatic synthesis of Met-enkephalin where the N- 
α protection of the amino terminal tyrosine residue was provided by the trypsin labile 
benzoylarginine moiety. The free Met-enkephalin was finally obtained by the action of 
trypsin in protected Met-enkephalin as shown in scheme 2.5. 
 
                                      Bz-Arg-Tyr-Gly-Gly-Phe-Met-OH           
                                                                     
                                                                   Trypsin 
                                                        
                                              Bz-Arg-OH  +  H-Tyr-Gly-Gly-Phe-Met-OH  
 
Scheme 2.5 Cleavage of the Bz-Arg group by trypsin during the synthesis of Met- 
                    enkephalin. 
 
The trypsin labile protecting group was also used by Glass (1987) to synthesize oxytocin, 
deaminooxytocin and oxypressin. If there are no basic amino acids like arginine or lysine 
in the target peptide, then trypsin labile protecting group can be employed. In the current 
research, there is no basic amino acid in the CCK-8 sequence therefore Bz-Arg can be 
used as an amino protecting group which can be introduced and cleaved by trypsin. 
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2.2 Aim of the research 
The aim of this research is to circumvent the drawbacks mentioned in the state of art (2.1) 
and to obtain a better way to synthesize free CCK-8. The chemical structure of free CCK-
8 is outlined in figure (2.1). 
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Figure 2.1 Structure of the target octapeptide of cholecystokinin.  
 
To obtain free CCK-8, the following points will be taken into account. 
(1) In the literature of CCK-8 syntheses, to the best of my knowledge, I have not found 
any literature mentioned about a suitable N- α protecting group which can be removed 
enzymatically. Either the protecting group has been cleaved chemically (Kullmann, 1988; 
Cerovsky et al., 1988) or the protecting group has not been cleaved at all (Fite et al., 
2002). Therefore, there is a need for a N- α protecting group which can be cleaved 
enzymatically. Moreover, the protecting group should be easy to be introduced, should be 
inert to the condition prevailing during reaction steps and should be easy to be removed 
at the end of the reaction. The introduction of the protecting group is also an essential 
requirement for ensuring the synthesis of well defined peptides and for suppressing the 
zwitterionic character of the reactants. Therefore in this work, another protecting group 
(Bz-Arg) besides Phac will be exploited for N- α protection during enzymatic synthesis. 
According to our experience, the longer the peptide chain, the more difficult it is to 
cleave the Phac group. Therefore, Bz-Arg will be investigated as a useful protecting 
group for the synthesis of the protected CCK-8. It was investigated in our laboratory that 
the aspartate unit having a methyl ester side chain was better than the free carboxylic acid 
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side chain during the synthesis of cholecystokinin tetrapeptide (CCK-4). With the ester 
side chain in aspartate, the solubility was higher in organic solvent, fewer by-products 
were formed and better yield was obtained. Moreover, the introduction and removal of 
ethyl and methyl ester is also simple. Therefore, in this work, ethyl and methyl ester will 
be applied for the side chain protection of aspartic acid. 
 
 (2) Enzymatic synthesis of different fragments of CCK-8 will be carried out so that there 
could be different possibilities of fragment condensation for the final assembly of CCK-
8. Different fragments like Bz-Arg-Asp(OEt)-Tyr-Met-OH/OAl, H-Gly-Trp-OMe, Phac-
Gly-Trp-Met-OH/OAl, H-Asp(OMe)-Phe-NH2 will be synthesized. The influence of 
structures and concentrations of acyl-donors and nucleophiles, reaction media and 
carriers used to immobilize enzymes on both the product yield and enzymatic activity 
will be assayed. After the synthesis of protected CCK-8, N- α protecting group and side 
chain protecting group of aspartic acid will be cleaved to enable the successful synthesis 
of free CCK-8. 
 
The following two pathways will be explored to obtain the target octapeptide. 
 
(i) Bz-Arg-Asp(OEt)-Tyr-Met-OH/OAl + H-Gly-Trp-OMe 
                                               
                                               α-Chymotrypsin 
           
            Bz-Arg-Asp(OEt)-Tyr-Met-Gly-Trp-OMe 
 
H-Met-Asp(OMe)-Phe-NH2  α-Chymotrypsin 
 
Bz-Arg-Asp(OEt)-Tyr-Met-Gly-Trp-Met-Asp(OMe)-Phe-NH2 
 
                                               Trypsin 
                                                NaOH 
          H-Asp-Tyr-Met-Gly-Trp-Met-Asp-Phe-NH2 
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(ii) Phac-Gly-Trp-Met-OH/OAl + H-Asp(OMe)-Phe-NH2 
 
                                                 α-Chymotrypsin 
 
             Phac-Gly-Trp-Met-Asp(OMe)-Phe-NH2 
                                                   
                                                 PGA 
 
                H-Gly-Trp-Met-Asp(OMe)-Phe-NH2 
 
 
Bz-Arg-Asp(OEt)-Tyr-Met-OH/OAl + H-Gly-Trp-Met-Asp(OMe)-Phe-NH2 
 
                                                 α-Chymotrypsin 
 
 
Bz-Arg-Asp(OEt)-Tyr-Met-Gly-Trp-Met-Asp(OMe)-Phe-NH2 
                                                   
                                                  Trypsin 
                                                  NaOH 
 
              H-Asp-Tyr-Met-Gly-Trp-Met-Asp-Phe-NH2 
 
(3) During the enzymatic synthesis, the enzymes could cleave at different positions of 
peptides and can assemble in an unexpected way so it is relatively difficult to be sure for 
the product formed during an enzymatic way. Therefore it is always good to have a 
reference product with which the progress of the reaction can be monitored in HPLC. For 
this reason, reference substances will be prepared using the chemical strategy in case 
reference substances are not already available in our laboratory. 
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(4) If possible, immobilized enzymes will be utilized in place of free enzymes. The 
advantages of immobilized over free enzymes arise from their enhanced stability in 
organic solvents, ease of separation from reaction media, easy recovery and repeated use. 
The immobilized enzyme can be completely removed from the solution. This is 
especially important for the therapeutical application of peptides. When the peptide is 
contaminated with enzymes, it can show immunological reactions if it is used in 
therapeutical application. Different methods will be utilized to immobilize enzymes and 
the activity of the immobilized enzymes will be assayed. 
  
(5) Different reaction systems will be applied for optimizing the reaction. The reaction 
will be carried out either in aqueous system (i.e. the reaction in plain water or in buffer) 
or in co-solvent system (water miscible solvents like alcohols or DMF can be applied as 
organic solvent) or in bi-phasic system (water and water-immiscible organic solvent are 
taken, if the acyl donor and nucleophile are soluble in water whereas the product is better 
soluble in the organic phase) or in the solvent free system (water needed for the enzyme 
will be provided by the crystalline water of sodium or potassium salts). The reaction in 
the solvent free system is done in the solid state. 
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 2.3 Characterization of the products 
Many analytical methods can be applied to confirm the structure of a product. In this 
research, elemental analysis is not very useful because all the peptides will have the same 
elements like C, H, O and N. As a result the values determined by elemental analysis will 
not largely differ from peptide to peptide. The information gained in this method will not 
give convincing proof in the structure confirmation. 
 
Thin layer chromatography is optimal and easy to perform. Besides detecting the UV 
active substances by TLC with the UV lamp, the UV inactive substances could be 
detected with the ninhydrin test followed by the chlorine/tolidine test.  
 
HPLC is highly useful for following the kinetics of a reaction. RP-HPLC examination of 
the peptides allows rapid separation and quantification of the components in a mixture. 
 
If reference substances were available, the products were compared with the properties of 
the reference samples in terms of melting point, retention time in RP-HPLC and Rf value 
in TLC. The final structure was determined by MS analysis. If the molecular mass is as 
calculated, the peptide sequence will be assumed to be according to the schedule of the 
synthesis. 
 
In this work, the purity of the sample is determined by HPLC. If there is a single 
symmetrical peak of correct retention time, one can assume that the sample is pure. 
 
Racemization occurs either in strongly acidic or strongly basic condition or during the 
activation of the carboxyl group. In this work, enzymatic methods are used for coupling 
and consequently there is no question of optical purity as there is no danger of 
racemization. Even if the substrate is racemized to some extent, the enzymes are highly 
specific and selective to couple only the L-isomer for the next coupling steps. Therefore, 
optical purity was not measured in this study. 
As a conclusion, it can be said that the structure determination was done by MS analysis 
and the purity of the product was checked by HPLC. 
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3 Results and discussion 
 
3.1 Enzyme immobilization and activity test 
 
(1) Immobilization 
Before carrying out the activity test of a particular enzyme, the immobilization of trypsin, 
papain and α-chymotrypsin on different carriers was done. In this work, immobilization 
was done in two ways. Either the enzyme was just deposited on Celite-545 without any 
chemical bond or the enzyme was attached to VA-Epoxy or Eupergit C with a chemical 
bond. The epoxy polymer (VA-Epoxy) is formed by refluxing the VA-Hydroxy-Biosynth 
together with epichlorohydrin. However, Eupergit C is an already epoxydised acryl resin. 
Then the amino group of the enzyme attacks the epoxy group of VA-Epoxy or of 
Eupergit C and forms a covalent binding to the corresponding polymer. 
 
The details regarding the immobilization and their stability has already been published by 
our group (Eckstein and Renner, 1992; Eckstein et al., 1991) 
 
The activity of immobilized enzymes was tested prior to its use. The activity was also 
checked after multiple uses or prolonged storage of the immobilized enzyme. The 
detailed study regarding individual immobilized enzymes is mentioned below. 
 
(2) Activity test of immobilisates 
Trypsin. It was immobilized on Eupergit C (Trypsin/Eupergit C). The activity of 
immobilized trypsin was checked using Bz-Arg-OEt·HCl as substrate. In presence of 
phosphate buffer (pH 7.5), the trypsin converted the substrate to Bz-Arg-OH. The 
conversion of Bz-Arg-OEt to Bz-Arg-OH was followed in HPLC.  
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Figure 3.1 Hydrolysis of Bz-Arg-OEt with trypsin/Eupergit C in phosphate buffer (pH   
                   7.5). 
 
As shown in figure 3.1, the activity of trypsin is good. Within 40 min, immobilized 
trypsin completely cleaved Bz-Arg-OEt to Bz-Arg-OH. Trypsin/Eupergit C was used to 
synthesize Bz-Arg-Asp(OEt)-OEt and to cleave Bz-Arg from both Bz-Arg-Asp(OEt)-
Tyr-Met-OH and Bz-Arg-Asp(OEt)-Tyr-Met-Gly-Trp-Met-Asp(OMe)-Phe-NH2. 
 
The activity of immobilisate was checked after multiple uses during a one year period. 
The result of the activity test (figure 3.2) shows that immobilized trypsin can be 
effectively used for three times. Even after the third application, the activity was still high 
but when this immobilisate was used to synthesize Bz-Arg-Asp(OEt)-OEt, the by-product 
(Bz-Arg-Asp(OEt)-OH) was formed more than the product. The probable reason could be 
that after multiple uses, protease activity of trypsin decreased but esterase activity was 
still there so the ester was cleaved. The next possibility could be because of the impurity 
(mainly α-chymotrypsin) present in the trypsin. When the catalytic activity of trypsin 
decreased after multiple uses, the catalytic activity of α -chymotrypsin cleaved the ester. 
In conclusion, the immobilisate could be used three times in a period of one year. The 
high stability of trypsin is caused by the covalent binding between enzyme and carrier. 
The multiple use of immobilisate is useful both in purifying the product and reducing the 
cost of the reaction.  
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Figure 3.2 Hydrolysis of Bz-Arg-OEt with Trypsin/Eupergit C. Activity directly after   
        immobilization (♦), after the first application (■), after the second application      
                   (▲) and after the third application (×). 
 
α-Chymotrypsin. The activity of α-chymotrypsin immobilized on Eupergit C (α-
CHY/Eupergit C) and on Celite-545 (α-CHY/Celite-545) was tested taking Ac-Tyr-OEt 
as substrate. The conversion of Ac-Tyr-OEt to Ac-Tyr-OH was followed in HPLC. 
 
As shown in figure 3.3, α-CHY/Celite-545 was able to hydrolyze the given substrate in 
10 min while α-CHY/Eupergit C required around 1 h. The activity of α-CHY/Celite-545 
was better but it could not be used after the first application where as α-CHY/Eupergit C 
was successful in synthesizing Phac-Gly-Trp-Met-OEt even after the first use of the 
immobilisate. The possible explanation could be that there is just physical adsorption on 
Celite whereas there is chemical covalent bond between enzyme and Eupergit C so α-
CHY/Eupergit C could retain its activity even after working up procedure. In some cases 
like synthesis of protected octapeptide (Bz-Arg-Asp(OEt)-Tyr-Met-OAl + Gly-Trp-Met-
Asp(OMe)-Phe-NH2), α-CHY/Eupergit C was superior than α-CHY/Celite-545 while in 
another synthesis of Bz-Arg-Asp(OEt)-Tyr-Met-OAl (Bz-Arg-Asp(OEt)-Tyr-OH + Met-
OAl·PTS) the opposite was found true. In economic point of view and keeping enzyme’s 
contamination away from the product, α-CHY/Eupergit C is superior than α-CHY/Celite-
545. 
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Figure 3.3 Hydrolysis of Ac-Tyr-OEt with α-CHY/Celite-545 (♦), and with α-CHY/   
                  Eupergit C (■) in 0.01 M Tris-HCl buffer (pH 8.1).  
 
Papain. Papain was immobilized on VA-Epoxy (papain/VA-Epoxy) and on Celite-545 
(papain/Celite-545). The activity of immobilized papain was tested taking Bz-Arg-OEt as 
substrate. The conversion of Bz-Arg-OEt to Bz-Arg-OH was followed in HPLC. 
  
As shown in figure 3.4, both immobilisates had almost the same activity so papain/VA-
Epoxy was taken for the synthesis of Phac-Gly-Trp-OMe. Papain/VA-Epoxy was better 
than papain/Celite-545 because of the covalent binding between papain and VA-Epoxy 
which could retain the activity even after the working up procedure.  
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Figure 3.4 Hydrolysis of Bz-Arg-OEt with papain/Celite-545 (♦) and with  
                  papain/VA-Epoxy (▲) in 0.5 M  KH2PO4 buffer (pH 6.0) in presence of  
                  EDTA and 2-mercaptoethanol. 
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Papain is a cysteine protease which binds to the active site of the substrate through a 
thioester linkage. Papain loses its activity even by aerial oxidation that is why the papain 
mediated reactions were performed in presence of 2-mercaptoethanol. 2-Mercaptoethanol 
can activate papain and maintain its activity even in the presence of air. EDTA is also 
added during the reaction mediated by papain whose main function is to complex any 
heavy metal ion, which could otherwise deactivate the –SH group of papain. 
 
PGA/Eupergit C (Fluka). Benzylpenicillin was used as the substrate for the activity test 
of PGA/Eupergit C. The conversion of benzylpenicillin to phenylacetic acid and 6-
aminopenicillanic acid was determined with HPLC. 
 
 
 
 
 
Scheme 3.1 Conversion of benzylpenicillin to phenylacetic acid and 6-aminopenicillic  
                    acid by immobilized PGA. 
 
The activity of the immobilized PGA was found effective as there was no starting 
material detected in HPLC after 30 min (figure 3.5). PGA/Eupergit C was used to cleave 
the protecting group Phac from Phac-Gly-Trp-OMe and Phac-Gly-Trp-Met-Asp(OMe)-
Phe-NH2. 
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Figure 3.5 Hydrolysis of benzylpenicillin with PGA/Eupergit C in 1 M    
                  KH2PO4 buffer (pH 7.5). 
Benzylpenicillin 
 
 
 
Phenylacetic acid 6-Aminopenicillic acid
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3.2 Synthetic strategy  
There are three possible strategies for the synthesis of peptides. 
 
(1) Fragment condensation 
Fragment condensation in the synthesis of peptides is possible in the enzymatic way 
because there is no danger of racemization. During the condensation of peptides in 
chemical way, there might occur racemization while activating the carboxyl group of the 
peptide. In this work, fragment coupling between Bz-Arg-Asp(OEt)-Tyr-Met-OAl and H-
Gly-Trp-Met-Asp(OMe)-Phe-NH2 was done successfully with the help of α-
CHY/Eupergit C. 
. 
(2) N        C strategy 
Starting with the N-terminal and adding one amino acid each time is the easy way of 
synthesizing peptides. To shift the equilibrium of the enzyme catalyzed peptide synthesis, 
highest possible concentration and excess of one fragment are necessary. Excess of the 
carboxyl group containing fragment may lead to product inhibition of the enzyme so it is 
better to apply amino acid ester or amide in excess which makes the synthesis cheap and 
operating procedure easy. This is also possible only in enzymatic way. In chemical way, 
this is not possible because even if the blocking group (urethane type) protects the first 
residue against racemization, in subsequent steps blocked peptides are activated and their 
activated C-terminal residues are exposed to the racemizing effect by the leaving group. 
In this work, Bz-Arg-Asp(OEt)-Tyr-Met-OAl and Phac-Gly-Trp-Met-Asp(OMe)-Phe-
NH2 were synthesized from N terminus to C terminus. 
 
(3) C        N strategy 
The synthesis of the peptides according to this strategy is laborious for practical purposes. 
In this strategy, each amino acid is added in the blocked and activated form and in a 
second step the amino blocking group is removed after each coupling. If each added new 
amino acid is protected by a blocking group of the urethane type, there is no substantial 
risk of racemization. In this work, C-terminal pentapeptide was synthesized from C to N 
terminus using the Fmoc as the N α-protecting group. 
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3.3 Enzymatic synthesis of the fragments  
The syntheses of several fragments of CCK-8 are described below. 
 
3.3.1 Bz-Arg-Asp(OEt)-Tyr-Met-OH/OAl  
This tetrapeptide, Bz-Arg-Asp(OEt)-Tyr-Met-OH/OAl is the N-terminal tripeptide 
fragment of CCK-8. The synthesis was started from the N-terminus and was continued 
adding one amino acid ester each time. For the synthesis of this tetrapeptide (N-terminal 
tripeptide fragment of CCK-8), there was little knowledge about the synthetic strategy 
and reaction conditions (Fite et al., 2002). In this work, benzoylarginine (Bz-Arg) was 
taken as an amino protecting group. As this group was new for the synthesis of CCK-
fragments, the effect of substrate structure, reaction media, enzyme and its carriers were 
studied in detail. The synthetic pathway is outlined in scheme 3.2. The synthesis of 
individual steps is described below. 
Bz-Arg-OEt·HCl Bz-Arg-Asp(OEt)-OEt
Trypsin/Eupergit C
Asp(OEt)-OEt·HCl
Free Papain
Tyr-OMe·HCl
Bz-Arg-Asp(OEt)-Tyr-OH
CHY/Celite-545Met-OEt·HCl
Met-OAl·PTS
Bz-Arg-Asp(OEt)-Tyr-Met-OAl
Bz-Arg-Asp(OEt)-Tyr-Met-OH
CHY/Celite-545
Trypsin/Eupergit C
H-Asp(OEt)-Tyr-Met-OH
(71.5%) (30.5%)
(38.7%)
(65.6%)
(63.9%)
(55%)a
 
Scheme 3.2 The N        C strategy for the synthesis of N-terminal tripeptide fragment of 
                   CCK-8. The isolated yields are shown in parentheses. aThe yield is calculated            
                    after the unreacted educts were recycled for a repeated conversion. 
Results and discussion 36 
Synthesis of Bz-Arg-Asp(OEt)-OEt. Bz-Arg as the protecting group can be introduced 
easily to Asp(OEt)-OEt and removed at the end of the synthesis with trypsin.  Enzymatic 
introduction and cleavage of protecting groups offer advantages over chemical methods 
due to their selectivity, specificity and mild operation condition. The reaction between 
Bz-Arg-OEt·HCl and Asp(OEt)-OEt·HCl to yield Bz-Arg-Asp(OEt)-OEt was kinetically 
controlled. The optimized reaction was conducted between 1 equivalent Bz-Arg-OEt·HCl 
and 2 equivalents Asp(OEt)-OEt·HCl under solvent free conditions similar to the method 
described by Cerovsky (1992). The system was made alkaline by adding solid Na2CO3 
and solid NaOH. The water needed for the enzyme was supplied by Na2CO3·10H2O. In 
this condition, the isolated yield of Bz-Arg-Asp(OEt)-OEt was 71.5% in 4 hours. If the 
reaction was not terminated at its optimum point, side reactions of immobilized trypsin 
(trysin/Eupergit C) were significant. The two by-products were achieved by the esterase 
activity of trypsin in which trypsin hydrolyzed the esters of both edduct (Bz-Arg-
OEt·HCl) and product (Bz-Arg-Asp(OEt)-OEt) giving rise to Bz-Arg-OH and Bz-Arg-
Asp(OEt)-OH respectively. The formation of Bz-Arg-OH is also possible from the 
proteolytic action of trypsin in Bz-Arg-Asp(OEt)-OEt. Both the by-products could be 
kept below 10% by monitoring the kinetics of the reaction in HPLC. The immobilized 
enzyme could be used three times without significant loss of activity which is one of the 
major advantages of immobilization. 
 
This synthesis was carried out in Tris-HCl buffer (0.1 M, pH 8.0) with the same 
immobilisates. In this case, only the by-products Bz-Arg-OH and Bz-Arg-Asp(OEt)-OH 
were obtained. 
 
Synthesis of Bz-Arg-Asp(OEt)-OH. The synthesis of this peptide was carried out via two 
methods. In the first method, Bz-Arg-Asp(OEt)-OEt was synthesized as mentioned above 
and in analogy to our earlier reported findings ( Meng et al., 2006), already synthesized 
Bz-Arg-Asp(OEt)-OEt was selectively hydrolysed by α-chymotrpsin to yield Bz-Arg-
Asp(OEt)-OH. The second method to synthesize Bz-Arg-Asp(OEt)-OH was the reaction 
between Bz-Arg-OEt·HCl and Asp(OEt)-OEt·HCl in water with immobilized trypsin.  
The isolated yield of the product in first and second method was 38.8% and 41.2% 
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respectively. The second method was superior to first method because the isolated yield 
was better and the numbers of reaction steps were less. 
 
Bz-Arg-Asp(OEt)-OH was tried to extend to Bz-Arg-Asp(OEt)-Tyr-OMe. In our earlier 
reported findings (Meng et al., In Press), free carboxylic acid in Phac-Asp(OMe)-OH 
reacted with Tyr-OAl·TOS to yield Phac-Asp(OMe)-Tyr-OAl in presence of thermolysin. 
However, the free carboxylic acid in Bz-Arg-Asp(OEt)-OH could not be reacted with 
Tyr-OMe·HCl in presence of thermolysin. 
 
Synthesis of Bz-Arg-Asp(OEt)-Tyr-OH. The optimized coupling between Bz-Arg-
Asp(OEt)-OEt and 1.5 equivalents Tyr-OMe·HCl was performed in 20 equivalents of 
KHCO3 and 0.25 equivalents of Na2SO4·10H2O in presence of free papain. The isolated 
yield was 30.5%. In the synthesis of this peptide, it was possible to convert Bz-Arg-
OEt·HCl to Bz-Arg-Asp(OEt)-Tyr-OH in a one pot reaction without purification and 
isolation of Bz-Arg-Asp(OEt)-OEt as illustrated in scheme 3.3. 
 
Bz-Arg-OEt·HCl remove enzyme by filtration
Bz-Arg-Asp(OEt)-Tyr-OH
Asp(OEt)-OEt·HCl
Trypsin/Eupergit C
Tyr-OMe·HClfree papain
Enzyme removal by filtration
 
 
Scheme 3.3 Two steps reactions in a one pot reaction, illustrated by converting Bz-Arg-       
                    Asp(OEt)-Tyr-OH from Bz-Arg-OEt·HCl without isolating the intermediate   
                    Bz-Arg-Asp(OEt)-OEt. 
 
When the reaction between Bz-Arg-Asp(OEt)·HCl and Asp(OEt)-OEt·HCl had its 
highest HPLC conversion, the product was dissolved in 80% ethanol and the immobilized 
trypsin was separated. The resulting product was concentrated and Tyr-OMe· HCl was 
added in the ratio mentioned above and the reaction was again performed under solvent 
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free conditions. Thus by using the immobilized enzyme, a three step reaction could be 
performed in two steps. 
 
Synthesis of Bz-Arg-Asp(OEt)-Tyr-Met-OH. Bz-Arg-Asp(OEt)-Tyr-OH and 5 
equivalents Met-OEt·HCl were suspended in Tris-HCl buffer (0.1 M, pH 8.1) containing 
10% acetonitrile. The product Bz-Arg-Asp(OEt)-Tyr-Met-OH was formed in an isolated 
yield of 38.7% in 6 hours. The unreacted starting material Bz-Arg-Asp(OEt)-Tyr-OH was 
recovered and recycled for a repeated conversion. With this method, the isolated yield of 
product could be increased to 55%. 
 
Synthesis of Bz-Arg-Asp(OEt)-Tyr-Met-OAl. The activity of the OCam ester is the 
highest among the benzyl, methyl and Cam esters (Capellas et al.,  1996a) but Bz-Arg-
Asp(OEt)-Tyr-Met-OCam could not be prepared from Bz-Arg-Asp(OEt)-Tyr-Met-OH 
via the chemical strategy because the tyrosine residue in this sequence was not protected. 
The next approach was to use Met-OAl as a nucleophile and to end up in allyl ester (Bz-
Arg-Asp(OEt)-Tyr-Met-OAl) so that the resulting peptide can be used as an acyl donor 
without any modification in the next fragment coupling. The use of allyl ester in the 
synthesis of protected CCK-8 was reported by Fite et al., (2002). 
  
Bz-Arg-Asp(OEt)-Tyr-OH and 2.5 equivalents Met-OAl·PTS were suspended in 
acetonitrile containing 3.75% Tris-HCl buffer (0.1 M, pH 8.1). The reaction was 
catalyzed by α-CHY/Celite-545. At 48 hours, the reaction was stopped and the isolated 
yield of the pure Bz-Arg-Asp(OEt)-Tyr-Met-OAl was 63.9%. During this reaction, the 
hydrolyzed product (Bz-Arg-Asp(OEt)-Tyr-Met-OH) was also formed but it could be 
kept below 5% by optimizing the conditions. In this reaction, the amount of buffer played 
a crucial role to direct the reaction pathway either towards the target product or towards 
the hydrolyzed product.  
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Figure 3.6 Kinetic process of the synthesis of Bz-Arg-Asp(OEt)-Tyr-Met-OAl (■) from  
                  0.3 mmol Bz-Arg-Asp(OEt)-Tyr-OH (♦) in 8 ml acetonitrile containing 3.75%  
                  Tris-HCl buffer in presence of α-CHY/Celite-545. 
 
As shown in figure 3.6, the product yield increased steadily up to 48 h and then there was 
no improvement in the yield. Instead, the product was hydrolyzed to Bz-Arg-Asp(OEt)-
Tyr-Met-OH. The reaction was terminated at this point. In the figure 3.7, HPLC 
chromatograms of this synthesis at time 0 and 48 hours are shown. At 48 hours, the peak 
of Bz-Arg-Asp(OEt)-Tyr-OH nearly vanished and the target product as well as the by-
product was formed. 
 
    
                            (a)                                                    (b) 
                  
      Figure 3.7 HPLC-chromatograms of the synthesis of Bz-Arg-Asp(OEt)-Tyr-Met-OAl     
                        from Bz-Arg-Asp(OEt)-Tyr-OH and Met-OAl·PTS at 0 min (a) and 48 hrs    
                        (b). 
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3.3.2 H-Gly-Trp-OMe 
This dipeptide was synthesized in order to investigate the fragment coupling between Bz-
Arg-Asp(OEt)-Tyr-Met-OH/OAl and Gly-Trp-OMe. The synthesis of Phac-Gly-Trp-
OMe and the cleavage of its Phac group is described below. 
 
Phac-Gly-Trp-OMe. The enzymatic reaction between Phac-Gly-OH and Trp-OMe·HCl 
to synthesize Phac-Gly-Trp-OMe was unsuccessful. However the condensation to Phac-
Gly-Trp-OMe was successful when Phac-Gly-OCam was employed as an acyl donor and 
Trp-OMe was employed as a nucleophile in EtOAc in presence of papain/VA Epoxy. 
Making  the Cam ester is a lengthy and laborious process.  
 
Glycine is an optically inactive amino acid so there is no danger of racemization during 
carboxyl activation of glycine in chemical synthetic strategy. That is why, Phac-Gly-Trp-
OMe was better synthesized using the DCC method and the isolated yield was 74%.  
 
This dipeptide was treated with PGA in order to remove the Phac group. PGA was added 
to the suspension of dipeptide in water (pH 7.6).  In this reaction, after 80 hours, 32.6% 
diketopiperazines and only 8.4% free Gly-Trp-OMe was observed in HPLC.  As soon as 
free Gly-Trp-OMe was formed, there was internal nucleophilic attack from N of the 
amino group to the C of the carboxyl group to make 6-membered stable 
diketopiperazines. The reaction is shown in the scheme 3.4. 
                  
pH >7
CH 2 C
O
NH HC C
O
CH 2
N
H
NH2 OCH 3
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O
O  
Scheme 3.4 Formation of diketopiperazines from H-Gly-Trp-OMe at pH 7.6. 
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If the nucleophilicity of the NH2 group can be reduced by protonating it, then the rate of 
internal nucleophilic attack would reduce which in turn reduce the diketopiperazines 
formation. Therefore, the reaction was investigated in different acidic pH values. The 
higher temperature also favors diketopiperazine formations in this reaction, therefore the 
working up procedure (solvent removal) was done at 25º C. The isolated yield of the free 
dipeptide could be increased to 36.3% at pH 6.0. 
 
The scheme of synthesis of H-Gly-Trp-OMe is outlined in scheme 3.5. 
 
Phac-Gly-OH Phac-Gly-OCam Phac-Gly-Trp-OMe
H-Gly-Trp-OMe
Trp-OMe·HCl
Trp-OMe·HCl
Papain/VA Epoxy
PGA/Eupergit C
DCC
pH 6
(60.6%)
(74%)
(90%)
(36.3%)
1.Cs2CO3
2.ClCH2CONH2
 
Scheme 3.5 Enzymatic and chemical synthesis of Phac-Gly-Trp-OMe and the cleavage     
                     of Phac from Phac-Gly-Trp-OMe. The isolated yields are shown in   
                     parentheses.  
 
The results of effect of pH in the synthesis of free Gly-Trp-OMe are mentioned in table 
3.1. As can be seen in this table, there was highest conversion at pH 6.0 and pH below 
5.0 was not good for the enzymatic activity. 
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Table 3.1 Effect of pH in the cleavage of Phac from Phac-Gly-Trp-OMe. 
pH Time [h] HPLC conversion (%) 
4.5 24 23.4 
5.0 24 10.6 
5.5 24 32.5 
6.0 20 47.8 
6.5 20 35.2 
 
3.3.3 Phac-Gly-Trp-Met-OEt/OAl  
Phac-Gly-Trp-OMe was converted to two different tripeptide esters, Phac-Gly-Trp-Met-
OEt and Phac-Gly-Trp-Met-OAl. Phac-Gly-Trp-Met-OEt was obtained by reacting one 
equivalent of Phac-Gly-Trp-OMe, 4 equivalents of Met-OEt·HCl, 20 equivalents of 
KHCO3 and 4 equivalents of Na2CO3·10H2O in the presence of α-CHY/Eupergit C. The 
isolated yield of Phac-Gly-Trp-Met-OEt was 62.7%. The major by-product (Phac-Gly-
Trp-OH) formed by the hydrolysis of the educt was 26% (HPLC yield). The other by-
products like the Met-Met oligomer (Phac-Gly-Trp-Met-Met-OEt), hydrolysed tripeptide 
(Phac-Gly-Trp-Met-OH) were kept below 5% by monitoring the reaction in HPLC. The 
synthesis of Phac-Gly-Trp-Met-OAl was done in analogy to that of Phac-Gly-Trp-Met-
OEt. Basic, neutral and acidic solvent free systems were created by changing the salts and 
then the reaction was investigated in each system for the optimization. The highest 
isolated yield (60.1%) was obtained at 4 hours when one equivalent of Phac-Gly-Trp-
OMe, 1.5 equivalents of Met-OAl·PTS, one equivalent of KHCO3 and 0.3 equivalents of 
Na2CO3·10H2O were incubated in presence of α-CHY/Celite-545. The following scheme 
shows the reaction pathways leading to Phac-Gly-Trp-Met-OEt and Phac-Gly-Trp-Met-
OAl. 
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Phac-Gly-OCam Phac-Gly-Trp-OMe
Trp-OMe·HCl
Papain/VA Epoxy
Met-OEt·HCl
Met-OAl·PTS
Phac-Gly-Trp-Met-OAl
Phac-Gly-Trp-Met-OEt
(60.1%)
(62.7%)
(90.0%) CHY/Celite-545
CHY/VA-Epoxy
 
 
Scheme 3.6 Synthesis of Phac-Gly-Trp-Met-OAl and Phac-Gly-Trp-Met-OEt .The   
                     isolated yields of products are shown in parentheses. 
 
Figure 3.8 shows the chromatograms of the synthesis of Phac-Gly-Trp-Met-OAl at 0 and 
4 hours. As can be seen in figure 3.8 (b), Phac-Gly-Trp-OMe nearly disappears within 4 
hours and the only one by-product (Phac-Gly-Trp-OH) appears in a small peak at a 
retention time of 4.5 min. Therefore, the reaction was terminated at 4 hours. 
 
    
                       (a)                                                        (b) 
 
 Figure 3.8 Synthesis of Phac-Gly-Trp-Met-OAl from Phac-Gly-Trp-OMe and Met-OAl·  
                    PTS at 0 min (a) and 4 hrs (b). 
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3.3.4 H-Asp(OMe)-Phe-NH2 
Z-Asp(OMe)-Phe-NH2. The Z group was chosen to protect the N α-amino group because 
the Z group could be cleaved by catalytic hydrogenation in 15 min with more than 95% 
isolated yield. One equivalent Z-Asp(OMe)-OH and 1.3 equivalents H-Phe-NH2·HCl 
were suspended in water at pH 7. The reaction was carried out in presence of thermolysin 
at 40 ºC, the optimal temperature for this enzyme. The isolated yield of this dipeptide was 
96.8%.  
 
The protected dipeptide amide was subjected to hydrogenation in presence of Pd/C in 
order to remove Z group. The isolated yield at this step was 96.4%. 
 
Z-Asp(OMe)-OH
pH 7
Z-Asp(OMe)-Phe-NH2
H-Phe-NH2·HCl
H2/Pd-C
H-Asp(OMe)-Phe-NH2
(96.4%)
(96.8%)
 
Scheme 3.7 Synthesis of Z-Asp(OMe)-Phe-NH2 and the cleavage of Z group from Z-    
                    Asp(OMe)-Phe-NH2. The isolated yield of the products are shown in  
                    parentheses. 
 
3.3.5 Phac-Gly-Trp-Met-Asp(OMe)-Phe-NH2 (3+2) 
One strategy to synthesize Gly-Trp-Met-Asp-Phe-NH2 (CCK-5) has been already 
published by our group (Xiang et al., 2004). In the reported strategy Gly-Trp-Met-Asp-
Phe-NH2 was obtained by coupling Phac-Gly-Trp-Met-OCam and H-Asp(OMe)-Phe-
NH2 in acetonitrile with α-chymotrypsin, immobilized on Celite-545, followed by basic 
hydrolysis of the β-methyl ester, and removal of the Phac group with PGA. It should be 
mentioned that there were two chemical reaction steps necessary to transfer the ethyl 
ester of Phac-Gly-Trp-Met-OEt to the OCam ester of Phac-Gly-Trp-Met-OCam. 
 
In order to optimize the strategy by avoiding the OCam ester at the tripeptide fragment, in 
this work the fragment condensation between tripeptide and dipeptide is reported. The 
earlier mentioned allyl ester (Phac-Gly-Trp-Met-OAl) was reacted with 2.5 equivalents 
of H-Asp(OMe)-Phe-NH2 to give Phac-Gly-Trp-Met-Asp(OMe)-Phe-NH2. The reaction 
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was carried out in ethyl acetate containing both 6.6% Tris-HCl buffer (0.1 M, pH 8.1) 
and 4% Borax buffer (0.1 M, pH 8.2) in presence of α-CHY/Celite-545. The isolated 
yield of the product was 54%. The by-product Phac-Gly-Trp-Met-OH was ca.2% (HPLC 
yield). Thus, by using the allyl ester, the earlier procedure of the synthesis of the 
pentapeptide could be improved by reducing the number of synthetic steps.  
 
Figure 3.9 (b) shows the HPLC chromatogram of the synthesis of Phac-Gly-Trp-Met-
Asp(OMe)-Phe-NH2 at 95 hours. After this time, the target product started to decrease so 
the reaction was stopped at this point. 
 
 
                       (a)                                                              (b) 
    
Figure 3.9 HPLC chromatograms of the synthesis of Phac-Gly-Trp-Met-Asp(OMe)-Phe- 
                   NH2 from Phac-Gly-Trp-Met-OAl and Asp(OMe)-Phe-NH2 at 0 min (a) and  
                   95 hrs (b). 
 
3.4 Cleavage of Bz-Arg from Bz-Arg-Asp(OEt)-Tyr-Met-OH 
The Bz-Arg protecting group was considered for the N α-amino protection of the final 
CCK-8. Therefore it was important to check whether it can be cleaved from the tripeptide 
or not. If it can be cleaved from the tripepetide, there is a high chance that it will also be 
cleaved from the octapeptide. The deprotection is outlined in scheme 3.8. 
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Bz-Arg-Asp(OEt)-Tyr-Met-OH Bz-Arg-OH H-Asp(OEt)-Tyr-Met-OH
(65.6%)
Trypsin
H2O/pH 7.6
 
 
Scheme 3.8 Cleavage of Bz-Arg from Bz-Arg-Asp(OEt)-Tyr-Met-OH.  
 
The reaction was carried out in water in presence of free trypsin or trypsin/Eupergit C. In 
fact, both free enzyme and immobilized enzyme had the same effect for deprotection so 
immobilized trypsin was chosen as it can be separated from the solvent just by filtration. 
Moreover, the enzyme does not contaminate the product. The yield of H-Asp(OEt)-Tyr-
Met-OH was 65.6% after isolation. 
   
The reaction was investigated at two different pH values to optimize the reaction 
conditions. At pH 7.6, the isolated yield was 65.6% after 24 hours and at acidic pH 5.5, 
the HPLC conversion was only 12.5% after 48 hours.  
 
Three different products were verified by FAB-MS when the trypsin immobilisate 
obtained earlier and from another company was used.  
 
Bz-Arg-Asp(OEt)-Tyr-Met-OH Bz-Arg-OH
Trypsin
+ H-Asp(OEt)-Tyr-OH H-Tyr-Met-OH+
Diketopiperazine Diketopiperazine
H2O/pH 7.6
 
  
Scheme 3.9 Cleavage of Arg-Asp, Asp-Tyr- and Tyr-Met bonds by trypsin leading to  
                     the formation of diketopiperazines. 
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The trypsin was found to cleave at three different positions, Arg-Asp, Asp-Tyr and Tyr-
Met. Two six member stable rings (diketopiperazine) formed from two individual 
fragments because of the internal nucleophilic attack from amino end to carboxyl end as 
shown in scheme 3.9. This unusual cleavage is probably caused by the impurities present 
in the trypsin. α-Chymotrypsin is the most common impurity in trypsin. Therefore, in 
later deprotection steps, TPCK trypsin was used in which the catalytic action of α-
chymotrypsin is blocked.  
 
3.5 Deprotection of the C-terminal pentapeptide (Phac-Gly-Trp-Met-Asp(OMe)-
Phe-NH2) 
The Phac-pentapeptide Phac-Gly-Trp-Met-Asp(OMe)-Phe-NH2 contains two protecting 
groups: one is the β-methyl ester of the Asp residue, which could be easily removed by 
alkaline hydrolysis; the other is the N α-Phac group, which could be removed 
enzymatically by PGA/Eupergit C. 
 
The fully deprotection of Phac-Gly-Trp-Met-Asp(OMe)-Phe-NH2 was conducted in two 
steps. In the first step, the Phac-pentapeptide with the free β-carboxyl group in the 
aspartic acid residue was achieved through hydrolysis of Phac-Gly-Trp-Met-Asp(OMe)-
Phe-NH2 by NaOH in acetone/water (1:1). After acidification and washing, Phac-Gly-
Trp-Met-Asp(OH)-Phe-NH2 could be obtained with the isolated yield of 80.4%. In the 
second step, the removal of the Phac group from Phac-CCK-5 was carried out in water at 
pH 7.6 and 35º C with PGA/Eupergit C. After 24 hours, free CCK-5 was obtained. This 
isolated yield is lower than previously reported by our group (Xiang et al., 2004). One 
reason for the lower yield could be because a different batch of PGA was used. 
 
The selective deprotection of Phac from Phac-Gly-Trp-Met-Asp(OMe)-Phe-NH2 was 
conducted in one step. The reactant was suspended in water at pH 7.6 and PGA/Eupergit 
C was added. The yield of the reaction was low. This could be possible because of low 
solubility of the reactant in water. 
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Phac-Gly-Trp-Met-Asp(OMe)-Phe-NH2 Phac-Gly-Trp-Met-Asp(OH)-Phe-NH2
H-Gly-Trp-Met-Asp(OH)-Phe-NH2H-Gly-Trp-Met-Asp(OMe)-Phe-NH2
NaOH
PGA/Eupergit C PGA/Eupergit C pH 7.6pH 7.6
 
 
Scheme 3.10 Selective or complete deprotection of Phac-Gly-Trp-Met-Asp(OMe)- 
                      Phe-NH2. NaOH was used to cleave the methyl ester and immobilized PGA  
                      to cleave the Phac group. 
  
The free pentapeptide was needed to condense with the tripeptide segment to synthesize 
CCK-8. Because of the poor yield of the Phac-deprotection step, it was difficult to make 
enough free pentapeptide for the further condensation. Therefore, the free pentapeptide 
was synthesized chemically using Fmoc as protecting group. The chemical synthesis of 
CCK-5 from C-terminus to N-terminus is outlined in section 3.7. The next alternative for 
the synthesis of free CCK-5 would have been the use of Fmoc or Bz-Arg as N α- 
protecting group and to continue from N-terminus to C-terminus by enzymatic catalysis.  
 
3.6 Factors affecting the enzymatic synthesis of CCK-8 fragments 
 
3.6.1 N-terminal tripeptide fragment 
There is no general protocol available for enzymatic peptide synthesis. This is one of the 
drawbacks of enzymatic peptide synthesis. In order to suppress the competing hydrolysis 
reaction, the undesired oligomerization and the hydrolytic cleavage of the already formed 
peptide bonds, each coupling step has to be optimized. A series of reaction parameters 
such as optimal acyl-donor, nucleophile, reaction media, enzyme were investigated to 
find the best conditions for each reaction step. 
 
(1) Influence of the concentration and substrate structure 
Substrate concentration. It is well known that under normal condition, the equilibrium in 
protease catalyzed reactions is in the direction of proteolysis and not proteosynthesis. To 
shift the equilibrium of the enzyme catalyzed synthesis, an excess of one reactant and the 
highest possible concentration is needed besides other parameters which can shift the 
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equilibrium. In the stepwise elongation from Bz-Arg-OEt·HCl to Bz-Arg-Asp(OEt)-Tyr-
Met-OAl, it is better to apply the easily available nucleophile (amino acid ester) in 
excess. Beyond this, this is more economic also. The excess concentration of the carboxyl 
component may lead to ‘product inhibition’ of the enzyme. On the other hand, higher 
concentration of nucleophile may generate oligomer products as in the synthesis of Bz-
Arg-Asp(OEt)-Tyr-OH. When the ratio of Bz-Arg-Asp(OEt)-OEt and Tyr-OMe·HCl was 
1:4, the HPLC conversion of Bz-Arg-Asp(OEt)-(Tyr)n-OH (where n= 2, 3) was above 
10% and when the ratio was 1:1.5, the oligomer was kept below 5%. Therefore, it was 
important to optimize both, the concentration of acyl-donor and nucleophile. 
  
Structure of both, acyl-donor and nucleophile. As far as possible, ethyl and methyl 
esters were chosen as the acyl-donors in this work. These esters are cheap and easy to 
prepare in comparison to Cam ester, although the Cam ester has been reported as the 
most effective acyl-donor (Capellas et al., 1996a). For the synthesis of Bz-Arg-Asp(OEt)-
OEt, Bz-Arg-OEt·HCl was chosen as an acyl donor. The isolated yield of the 
condensation between Bz-Arg-OEt·HCl and Asp(OEt)-OEt·HCl was 71.5%  in solvent 
free condition under the catalytic influence of immobilized trypsin.  
 
For the extension of this sequence to Bz-Arg-Asp(OEt)-Tyr-OH, two different acyl- 
donors were used in solvent free condition under the catalytic influence of papain. The 
first acyl-donor Bz-Arg-Asp(OEt)-OH did not react with Tyr-OMe·HCl but the second 
one Bz-Arg-Asp(OEt)-OEt could react to give 30.5% product. This is generally the case 
in peptide synthesis where peptide esters react better than peptides with a free carboxylic 
acid. From the kinetics of papain-catalyzed peptide synthesis, esterified acyl-donors 
should be preferable than acyl-donors having a free carboxyl group (Oka and Morihara, 
1978). When the sequence was further extended to Bz-Arg-Asp(OEt)-Tyr-Met-OAl/OH 
with α-chymotrypsin/Celite 545, the free carboxylic acid (Bz-Arg-Asp(OEt)-Tyr-OH) 
could react with both Met-OEt·HCl and Met-OAl·PTS to form Bz-Arg-Asp(OEt)-Tyr-
Met-OH (isolated yield 65.6%) and Bz-Arg-Asp(OEt)-Tyr-Met-OAl (isolated yield 
63.9%) respectively. Synthesis by free carboxylic acid as acyl-donor is not so common in 
peptide synthesis but this case was observed many times in our laboratory. 
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For the synthesis of Bz-Arg-Asp(OEt)-Tyr-Met-OH/OAl, both nucleophiles, Met-
OEt·HCl and Met-OAl·PTS could react. But the selection of the amino group was made 
taking into account its reactivity as well as the possibility that the product of this reaction 
will be the acyl-donor for the next one. In this case, Met-OAl·PTS was superior to Met- 
OEt·HCl because with Met-OAl·PTS, the obtained product Bz-Arg-Asp(OEt)-Tyr-Met-
OAl could be used directly for the next coupling step. 
 
 (2) Influence of the reaction media  
The solvent plays an important role in enzymatic peptide synthesis in organic media 
(Dordick, 1989; Cassells and Halling, 1989). Previous fundamental studies by Kisse et 
al., (1990; 1988) showed that both acetonitrile and ethyl acetate were the best solvents 
providing high enzymatic activities and product yields in some enzymatic dipeptide 
syntheses. 
 
The coupling between Bz-Arg-Asp(OEt)-OEt and Tyr-OMe was investigated in different 
reaction media. In acetonitrile containing Tris-HCl buffer and ethyl acetate containing 
borax buffer, neither α-chymotrypsin nor papain could catalyze the reaction. There was 
only hydrolysis of the reactant i.e. Bz-Arg-Asp(OEt)-OH was formed. The solvent free 
system, however worked well for this coupling. Different concentrations of 
KHCO3/Na2CO3·10H2O and KHCO3/Na2SO4·10 H2O were investigated for optimizing 
the yield of the reaction. The highest yield (30.5%) was obtained when one equivalent of 
Bz-Arg-Asp(OEt)-OEt was reacted with 1.5 equivalents of Tyr-OMe·HCl, 10 equivalents 
of KHCO3 and 0.25 equivalents of Na2SO4·10H2O in presence of free papain. When the 
reaction was carried out in neutral solvent free condition by adding Na2SO4·10 H2O in 
place of KHCO3 and Na2CO3, there was no reaction at all. 
 
For the next coupling reaction between Bz-Arg-Asp(OEt)-Tyr-OH and Met-OEt·HCl, the 
solvent free system in presence of α-chymotrypsin resulted in only 5% conversion of Bz-
Arg-Asp(OEt)-Tyr-Met-OH. When the same reaction was carried out in Tris-HCl buffer 
(0.1 M, pH 8.1) containing 10% acetonitrile in presence of α-CHY/Celite-545, the 
isolated yield of the product was 38.7%. By recycling the unreacted educt, the isolated 
yield could be increased to 55%. When the concentration of organic solution was 
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increased from 10% to 80% by mixing EtOH and ACN (EtOH:ACN= 5:3) in Tris-HCl 
buffer (0.1 M, pH 8.1), the product yield decreased from 38.7% to 31.1%. The idea to 
increase the organic solvent was to make the reactants more soluble in the system but the 
lower yield could have been probably caused by the denaturation of enzymes by organic 
solvent mixture.   
 
In the analogous way, Bz-Arg-Asp(OEt)-Tyr-OH and Met-OAl·PTS reacted in the 
acetonitrile containing Tris-HCl buffer (0.1 M, pH 8.1). The concentration of the buffer 
was very important in this reaction to direct the reaction to Bz-Arg-Asp(OEt)-Tyr-Met-
OAl or to Bz-Arg-Asp(OEt)-Tyr-Met-OH. When the reaction was conducted in Tris-HCl 
buffer (0.1 M, pH 8.1) containing 10% acetonitrile, there was only Bz-Arg-Asp-OEt-Tyr-
Met-OH formed however when the concentration of acetonitrile was increased from 10% 
to 96.2% under similar conditions, the isolated yield of Bz-Arg-Asp(OEt)-Tyr-Met-OAl 
was 63.9%. 
 
(3) Influence of the enzyme and carrier 
As far as possible, immobilized enzymes were used instead of free enzymes. The reaction 
between Bz-Arg-Asp(OEt)-OEt and Tyr-OMe·HCl failed when free papain was replaced 
by papain/VA-Epoxy. 
 
3.6.2 C-terminal pentapeptide fragment  
As done in the N-terminal tripeptide fragment of CCK-8, every coupling step was studied 
in detail for the synthesis of C-terminal pentapeptide. Different parameters for e.g. 
solvent, temperature, pH, acyl-donor structure, nucleophile structure, enzymes were taken 
into account for optimizing the yield in every step. 
 
(1) Influences of substrate structure and concentration 
Structure of acyl-donor and nucleophile. The chemical nature of the ester moiety of the 
acyl-donor has a strong influence on enzymatic activity and product yield in kinetically 
controlled synthesis (Schellenberger et al., 1991). When the formation of acyl-enzyme 
complex between acyl-donor and enzyme is high, the formation of other by-products is 
greatly minimized during the reaction. 
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In this work, Phac-Gly-OMe did not react with Trp-OMe in the presence of immobilized 
papain. The reaction however was possible with very good isolated yield (90%) only 
when the structure of acyl-donor was changed from methyl to Cam ester.  
 
The methyl ester in Phac-Gly-Trp-OMe was active enough to couple with both Met-OEt· 
HCl and Met-OAl·PTS under solvent free condition. The reaction with Met-OEt was 
catalyzed by α-CHY/Eupergit C and with Met-OAl was catalyzed by α-CHY/Celite-545. 
The isolated yield of both the products was almost the same (ca. 61%). The structure of 
the nucleophile was not really important for the yield of this step but the structure of the 
nucleophile was important for the further extension of the sequence.  
 
Both acyl-donors, Phac-Gly-Trp-Met-OEt and Phac-Gly-Trp-Met-OAl were tried for 
fragment condensation with H-Asp(OMe)-Phe-NH2. The ethyl ester of Phac-Gly-Trp-
Met-OEt was not active enough to couple with H-Asp(OMe)-Phe-NH2 and this 
condensation was carried out earlier in our laboratory by converting the ethyl ester into 
the Cam ester (Xiang et al., 2004). In this work, by choosing another nucleophile (Met-
OAl·PTS), it was possible to get Phac-Gly-Trp-Met-OAl directly. There was no need of 
any chemical modification in the allyl ester for fragment condensation with H-
Asp(OMe)-Phe-NH2. The isolated yield in the present work is 54%. The isolated yield 
(73%) in our earlier reported work becomes 60.4% if the final yield is taken into account 
by calculating the yield in every steps converting from ethyl ester to free carboxylic acid 
to Cam ester and finally to the target product. In this way, the synthesis of the 
pentapeptide was improved by reducing the number of steps as well as the required time 
of the reaction maintaining nearly the same yield. 
 
Substrate concentration. Substrate concentration affects both enzymatic activity and 
yield in protease catalyzed peptide synthesis. In all coupling reactions, the nucleophile 
exceeded the acyl-donor by at least fifty percent in a molar ratio. 
 
 
 
 
Results and discussion 53
(2) Influence of reaction media and temperature 
The influences of the reaction media for the synthesis of Phac-Gly-Trp-OMe was 
reported already by our group (Xiang et al., 2004). The extension of this dipeptide to 
Phac-Gly-Trp-Met-OAl was investigated in different reaction media. First, the 
condensation reaction between Phac-Gly-Trp-OMe and Met-OAl·PTS was performed in 
ethyl acetate containing 0.2% (Tris-HCl buffer, 0.1 M, pH 8.1,). α-Chymotrypsin was 
chosen for this coupling because there is an aromatic side chain of tryptophan at the P1 
position which is the primary specificity of α-chymotrypsin. There was only 3% product 
(Phac-Gly-Trp-Met-Asp(OMe)-Phe-NH2) and 20% by-product (Phac-Gly-Trp-OH). 
 
Then the reaction was performed in a solvent free condition using α-CHY/Celite-545. 
One equivalent of Phac-Gly-Trp-OMe was reacted with 4 equivalents of Met-OAl·PTS, 2 
equivalents of KHCO3 and 0.4 equivalents of Na2CO3·10H2O. The HPLC conversion of 
the product and by-product was 40.3% and 8.1% respectively. In another investigation, 
one equivalent of Phac-Gly-Trp-OMe was reacted with 4 equivalents of Met-OAl·PTS, 
20 equivalents of KHCO3 and 4 equivalents of Na2CO3·10H2O. The HPLC conversion of 
the product and by-product was 17.8% and 17.9%, respectively. This result showed that 
higher amount of basic salts and higher amount of crystalline water is not so suitable for 
this coupling therefore slightly basic, neutral and acidic conditions were prepared to 
optimize the yield of the reaction. 
   
Three different types of solvent free systems were made by choosing different salt 
systems. The basic solvent free system was prepared by taking 2 equivalents of KHCO3 
and 0.4 equivalents of Na2CO3·10 H2O. The neutral solvent free system was prepared by 
taking 1 equivalent of Na2SO4·10 H2O. Similarly, 0.5 equivalents of Na2SO4·10 H2O and 
1 equivalent of KHSO4 were mixed for the acidic solvent free system. When one 
equivalent of Phac-Gly-Trp-Met-OAl and 4 equivalents of Met-OAl·PTS were mixed to 
all three systems separately in presence of α-CHY/Celite-545, the basic system gave the 
highest yield. The results are shown in table 3.2. 
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Table 3.2 The HPLC yield of product, by-product and reactant observed when Phac-Gly- 
                  Trp-OMe and Met-OAl·PTS were mixed in three different solvent free   
                   systems differing in pH. 
HPLC yield (%) Reaction 
system 
(solvent free) 
Phac-Gly-Trp-Met-OAl Phac-Gly-Trp-OH Phac-Gly-Trp-OMe 
Basic 44.4 6.5 14.2 
Neutral 2.5 9.8 60.2 
Acidic - - 73.8 
 
Therefore, further optimization was carried out in the basic system to improve the yield. 
The best result was obtained when one equivalent of Phac-Gly-Trp-OMe, 1.37 
equivalents of Met-OAl·PTS, one equivalent of KHCO3 and 0.3 equivalents of 
Na2CO3·10 H2O were mixed in presence of α-CHY/Celite-545. Under this condition, the 
isolated yield of the product (Phac-Gly-Trp-Met-OAl) was 60.1%. 
 
For synthesizing Phac-Gly-Trp-Met-Asp(OMe)-Phe-NH2, the condensation of Phac-Gly-
Trp-Met-OAl with Asp(OMe)-Phe-NH2·HCl was investigated in different reaction 
systems which is outlined in table 3.3. α-CHY/Celite-545 was used in all systems. The 
reaction was unsuccessful under the solvent free and co-solvent systems. There was no 
effect in the reaction when the amount of enzyme and Tris-HCl buffer was increased to 
some extent in both systems. However, the coupling was observed in bi-phasic systems.  
The HPLC yield of Phac-Gly-Trp-Met-Asp(OMe)-Phe-NH2 was 24.3% when the 
reaction was carried out in ethyl acetate containing 0.35% Tris-HCl buffer (0.1 M, pH 
8.1). The HPLC yield increased to 34.2% when the Tri-HCl buffer (0.1 M, pH 8.1) was 
replaced by borax buffer (0.1 M, pH 8.2) and Et3N was added. The best result (HPLC 
yield 66.7%) was obtained when one equivalent of tripeptide reacted with 2.5 equivalents 
of dipeptide in ethyl acetate containing 6.6% Tris-HCl buffer (0.1 M, pH 8.1), 4% borax 
(0.1 M, pH 8.2) buffer and 0.3% Et3 N. After 95 h, the reactant, Phac-Gly-Trp-Met-OAl 
was completely finished and the isolated yield of target product was 54%. By optimizing 
the conditions, the by-product (Phac-Gly-Trp-Met-OH) could be kept at 2%.   
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Table 3.3 HPLC yield of product (Phac-Gly-Trp-Met-Asp(OMe)-Phe-NH2), by- 
                 product (Phac-Gly-Trp-Met-OH) and acyl-donor (Phac-Gly-Trp-Met-OAl)  
                 when acyl-donor and nucleophile were mixed in different reaction systems. α- 
                 CHY/Celite-545 was used to catalyze the reaction. * 10 µl Et3N were added.  
                 ** 20 µl Et3N were added. 
HPLC yield of (%) Reaction System Reactants Time 
[h] Product By-
product 
Acyl-
donor 
Solvent free 
(KHCO3: 0.2 mmol 
Na2CO3·10H2O: 0.04 
mmol) 
Acyl-donor: 0.1mmol 
Nucleophile: 0.2 mmol 
72 - 15.3 42.9 
Co-solvent* 
(ACN: 2 ml 
Tris-HCl: 10 µl, 0.1 M, 
pH 8.1) 
Acyl-donor: 0.1 mmol 
Nucleophile: 0.2 mmol 
72 - - 82.9 
Bi-phasic 
(EtOAC: 2ml 
Tris-HCl: 7 µl, 0.1 M, 
pH 8.1) 
Acyl-donor: 0.05mmol 
Nucleophile: 0.1 mmol 
96 24.3 12.0 36.8 
Bi-phasic* 
(EtOAc: 2 ml 
Borax: 8 µl, 0.1 M, 
pH 8.2) 
Acyl-donor: 0.1mmol 
Nucleophile: 0.2 mmol 
72 34.2 9.5 3.9 
Bi-phasic** 
(EtOAc: 6 ml 
Borax: 240 µl, 0.1 M, 
pH 8.2 
Tris-HCl: 400 µl, 0.1 M, 
pH 8.1) 
Acyl-donor: 0.2 mmol 
Nucleophile: 0.5 mmol 
95 66.7 2.0 - 
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The kinetics of tripeptide, dipeptide, by-product and product is shown in figure 3.10. As 
shown in the figure, the product yield increased sharply after 70 hours and after 96 hours, 
it decreased. At 70 hours, more immobilisate was added which caused the sharp rise in 
the product yield.  The reaction was stopped at 96 hours. 
 
                  
 
Figure 3.10 Kinetic process of the synthesis of Phac-Gly-Trp-Met-Asp(OMe)-Phe- 
                     NH2(▲) and the by-product Phac-Gly-Trp-Met-OH (▪) from 0.2 mmol      
                     Phac-Gly-Trp-Met-OAl (♦) and 0.5 mmol H-Phe-NH2·HCl (▄) in 6 ml ethyl  
                     acetate containing 4% borax buffer (0.1 M, pH 8.2), 6.6% Tris-HCl buffer  
                     (0.1 M, pH 8.1), 0.3% Et3N with α-CHY/Celite-545. 
 
3.7 Chemical synthesis  
Chemical synthesis was performed either to obtain references substances or to generate 
enough starting materials. Reference substances are necessary for the identification of the 
product peak while monitoring the enzymatic reactions in HPLC. In enzymatic peptide 
synthesis, the newly formed product is not always the target product. Many times, 
cleaved products are also formed so it is difficult to follow the reaction if there is no 
reference substance. However, in the chemical approach, the product is reliably formed if 
the reaction is done according to the standard well known procedures. There might be 
racemization and diketopiperazine formation during the reaction but it does not matter if 
the substances are used as reference materials. Most of the reference substances were 
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already available in our laboratory and the lacking substance ( Phac-Gly-Trp-Met-OAl)  
was synthesized prior to the enzymatic investigation.  
 
3.7.1 Synthesis of Phac-Gly-Trp-Met-OAl 
For the synthesis of Phac-Gly-Trp-Met-OAl, first of all, Phac-Gly-Trp-OMe was 
synthesized as described in 3.3.2.  The chemical synthesis of Phac-Gly-Trp-Met-OAl was 
done by mixing the equimolar amounts of HOBt and Phac-Gly-Trp-OH with 10% excess 
of DCC. After the activation, DCU was filtered off and Met-OAl·PTS was added to the 
solution. Attack of the amino component on the activated carbonyl C-atom of carboxyl 
component resulted in the formation of the Phac-Gly-Trp-Met-OAl.  
 
3.7.2 Synthesis of C-terminal pentapeptide 
Chemical synthesis of C-terminal pentapeptide was performed because the yield of free 
pentapeptide obtained by cleavge of Phac from Phac-Gly-Trp-Met-Asp(OMe)-Phe-NH2 
was not good enough. High amount of free pentapeptide is mandatory to carry out the 
further steps of CCK-8 synthesis. There could have been another possibility to replace the 
Phac group by other protecting groups like Fmoc or Bz-Arg in enzymatic synthesis of 
Phac-Gly-Trp-Met-Asp(OMe)-Phe-NH2  but the C       N way of chemical synthesis was 
performed because the reaction time was short (ca. 20 min) and the isolated yield was 
good in every step. However, the main problem observed during this chemical synthesis 
was the side reaction created by the ring closure of the side chain of aspartic acid. The 
details regarding the ring closure is given in 3.7.2.3.   
 
The chemical synthesis of the C-terminal pentapeptide fragments was carried out in 
solution phase in analogy to the literature (Kisfaludy and Schoen, 1983). The base-labile 
9-fluorenylmethyloxycarbonyl group (Fmoc) was applied for the protection of the amino 
group in acyl-donors and the pentafluorophenylester was used for the activation of the 
carboxyl group. The cleavage of the Fmoc group can take place by the basicity of the 
amino group to be acylated. Therefore, highly reactive pentafluorophenylesters was used 
to increase the rate of coupling and to prevent the side reaction created by Fmoc 
cleavage. The chemical synthesis of the C-terminal pentapeptide fragment via the  
C        N strategy is presented in scheme 3.11. 
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Scheme 3.11 Chemical synthesis of the C-terminal pentapeptide fragments. 
 
3.7.2.1 Synthesis of Fmoc amino pentaflurophenyl esters 
Fmoc-amino acid pentafluorophenyl esters were easily obtained in high yield (≥87.5%) 
from the equal molar ratio of Fmoc-amino acid and pentafluorophenol in EtOAc or a 
mixture of EtOAc and DMF using DCC as the coupling reagent. 
 
3.7.2.2 Synthesis of Fmoc-Gly-Trp-Met-Asp(OMe)-Phe-NH2 
Z-Asp(OMe)-Phe-NH2, easily obtained from thermolysin-controlled peptide synthesis in 
96.8% isolated yield, was hydrogenated with the Pd/C catalyst to afford Asp(OMe)-Phe-
NH2 in quantitative yield. The free dipeptide amide was condensed with an excess of 
Fmoc-Met-OC6F5 in DMF with addition of triethylamine. The obtained Fmoc-Met-
Asp(OMe)-Phe-NH2 was treated with 10% dimethylamine solution in DMF to remove 
the Fmoc-group. The peptide chain was elongated by repeating the condensation and 
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deprotection cycle until Fmoc-Gly-Trp-Met-Asp(OMe)-Phe-NH2 was achieved. The 
isolated yields were around 80% in every coupling and every deprotection step. FABMS 
was used to characterize the product in every step.  
 
3.7.2.3 Deprotection of Fmoc-Gly-Trp-Met-Asp(OMe)-Phe-NH2 
The fully deprotected pentapeptide Gly-Trp-Met-Asp(OH)-Phe-NH2 was achieved by 
hydrolysis with 5% NaOH in H2O/acetone in one step. When the reaction was finished, 
the pH was adjusted to 7.0. The acetone was removed in vacuum. After removal of the 
acetone, the product precipitated from water. 
 
The partially protected pentapeptide Gly-Trp-Met-Asp(OMe)-Phe-NH2 was obtained by 
cleaving the Fmoc group with 10% diethylamine. After the cleavage, other by-products 
were separated in MPLC. The isolated peak of Gly-Trp-Met-Asp(OMe)-Phe-NH2 from 
MPLC seemed to be homogeneous by HPLC in the methanol system but in the ACN 
system, this single peak was resolved into four peaks. All the four peaks were separated 
by preparative HPLC and found that the first peak was Trp-Met-Asp(OMe)-Phe-NH2 
followed by Gly-Trp-Met-Asp(OMe)-Phe-NH2. The next two successive peaks were the 
products formed by the ring closure of the Asp side chain of Trp-Met-Asp(OMe)-Phe 
NH2 (Compound 1) and Gly-Trp-Met-Asp(OMe)-Phe-NH2 (Compound 2), respectively. 
The chemical formulae of these two compounds are as follows: 
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NH CH
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CO NH CH
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                                                       Compound 1 
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To investigate further the ring closure of the free tetra and pentapeptide, a purified free 
tetrapeptide was used. The chromatogram of the free tetrapeptide is shown in figure 3.11 
(a). When the tetrapeptide dissolved in DMF was mixed with dimethyl amine, a new peak 
appears in figure 3.11 (b) which is the cyclic product of the tetrapeptide. When the 
mixture was heated at 50ºC just for couple of minutes, the concentration of the cyclic 
product increased rapidly as can be seen in figure 3.11 (c). Therefore, the removal of 
solvents during working up procedure was carried out at 25ºC to reduce the rate of ring 
formation. It can be concluded that ring formation takes place during the cleavage of the 
protecting group by dimethyl amine and the concentration of this by-product increases 
during the working up procedure. 
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 Figure 3.11 HPLC chromatogram of free tetrapeptide (a), after addition of dimethyl  
                      amine in tetrapeptide (b) and after heating the solution of dimethyl amine  
                      tetrapeptide (c).  
 
3.8 Enzymatic synthesis of the protected CCK-8 [3+ (3+2)] 
Two different strategies were explored for the final assembly of the octapeptide (CCK26-
33). In the first strategy, it was planned to couple Bz-Arg-Asp(OEt)-Tyr-Met-OH/OAl and  
Gly-Trp-OMe and then Met-Asp(OMe)-Phe-NH2 in order to synthesize Bz-Arg-
Asp(OEt)-Tyr-Met-Gly-Trp-Met-Asp(OMe)-Phe-NH2. The strategy can be described as 
[(3+2) +3] in an abbreviated form. 
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Scheme.3.12 Side reactions during the planned synthesis of Bz-Arg-Asp(OEt)-Tyr-Met-  
                      Gly-Trp-Met-Asp(OMe)-Phe-NH2. 
 
During the coupling of Bz-Arg-Asp(OEt)-Tyr-Met-OH/OAl with Gly-Trp-OMe, no 
target product could be detected because of two side reactions. First, the free Gly-Trp-
OMe underwent rapid internal nucleophilic attack to form diketopiperazine. Second, the 
acyl-donor peptide was cleaved by α–chymotrypsin to form Bz-Arg-Asp(Tyr)-OH. The 
side reactions are outlined in scheme 3.12. The fragment coupling neither worked in 
acetonitrile solvent containing Tris-HCl buffer nor in ethyl acetate containing borax 
buffer.   
 
The second strategy, however, was successful. The synthesis of CCK-8 commenced with 
the α-CHY/Eupergit C controlled coupling of Bz-Arg-Asp(OEt)-Tyr-Met-OAl and Gly-
Trp-Met-Asp(OMe)-Phe-NH2. The free pentapeptide Gly-Trp-Met-Ap(OMe)-Phe-NH2 
was obtained by coupling Phac-Gly-Trp-Met-OAl and H-Asp(OMe)-Phe-NH2 in ethyl 
acetate with α-CHY/Celite-545  followed by removal of the Phac group by immobilized 
PGA. Based on the many coupling reactions, the optimal strategy is outlined in scheme 
3.13 which can be described as [3+ (3+2)].  
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Scheme 3.13 The second strategy for the enzymatic synthesis of the octapeptide.  
The crucial fragment coupling between Bz-Arg-Asp(OEt)-Tyr-Met-OAl and H-Gly-Trp-
Met-Asp(OMe)-PheNH2 was performed as follows. The deprotected H-Gly-Trp-Met-
Asp(OMe)-Phe-NH2 was reacted with 2 equivalents of Bz-Arg-Asp(OEt)-Tyr-Met-OAl 
in ACN containing 0.65% Tris-HCl buffer (pH 7.0, 0.05 M) and 0.45% Et3N where the 
condensation took place with α-CHY/Eupergit C. After 118 hours, the isolated yield of 
protected CCK-8 was 17.1%. Different parameters were investigated in order to increase 
the yield. The isolated yield could not be improved by changing the reaction systems and 
the enzyme carriers as compiled in table 3.4. 
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Table 3.4 Synthesis of protected CCK-8 in different reaction media under the influence 
                 of different enzyme carrier. Tris-HCl buffer was 0.5%, 0.05 M, pH 7.0. Borax   
                 buffer was 0.4%, pH 8.2, 0.05 M.  
Reaction system Enzyme Isolated yield 
Solvent free α-CHY/Celite-545 - 
ACN  containing Tris-HCl buffer α -CHY/Celite-545 < 5% 
ACN containing Tris-HCl buffer Free α-chymotrypsin - 
ACN containing Tris-HCl buffer α-CHY/Eupergit C 17% 
Ethyl acetate containing borax buffer α-CHY/Eupergit C 9% 
  
As can be seen in the table, free α-chymotrypsin could not catalyze the reaction, however, 
when the same enzyme was immobilized on Eupergit C, the best result was obtained. 
This result is surprising because immobilized enzyme could catalyze the condensation 
which free enzyme failed to do so. This abnormal behavior could not be studied during 
this period. α-CHY/Celite-545 was also not suitable for this reaction. The reaction in 
acetonitrile containing 0.5% Tris-HCl buffer was better than in ethyl acetate containing 
borax buffer. 
 
The main cause for the low yield of the reaction was the hydrolysis of the allyl ester of 
Bz-Arg-Asp(OEt)-Tyr-Met-OAl to Bz-Arg-Asp(OEt)-Tyr-Met-OH. When the kinetic 
was analyzed, it was found that the rates of both condensation and hydrolysis were nearly 
the same. It means that both the target product and the hydrolysis product were formed at 
the same rate. Next, it was tried to lower the hydrolytic action of the enzyme by lowering 
the water content in the system. The amount of buffer was already low so the main source 
of water in the system was from α-CHY/Eupergit C, because it was always stored in the 
wet form after immobilization. This water content in the enzyme was reduced by washing 
the enzyme with ACN containing 0.5% Tris-HCl buffer. The result showed that there was 
no reaction at all. Therefore the best investigated way so far was to use α-CHY/Eupergit 
C.  
Unlike in other coupling steps, the acyl-donor in this reaction was added in double molar 
ratio to the nucleophile. The reason for this is that it is comparatively easier to prepare 
Bz-Arg-Asp(OEt)-Tyr-Met-OAl than H-Gly-Trp-Met-Asp(OMe)-Phe-NH2. 
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Figure 3.12 represents the synthesis of protected CCK-8 during the reaction period [(a) 
and (b)] and after purification (c)]. The reaction was slow and when more enzyme was 
added to speed up the reaction, the by-product (Bz-Arg-Asp(OEt)-Tyr-Met-OH) was 
formed faster than the target protected octapeptide.  
 
             
              (a)                                                                         (b) 
 
                           
                                                       (c) 
                                               
Figure 3.12 Synthesis of Bz-Arg-Asp(OEt)-Tyr-Met-Gly-Trp-Met-Asp(OMe)-Phe-NH2  
                    at 0 min (a), after 90 hrs (b) and after isolation (c).   
 
3.9 Cleavage of Bz-Arg from protected CCK-8 
The action of trypsin is restricted to the linkage of the carboxyl group of arginine or any 
other basic amino acid. Therefore, trypsin should split exclusively the Arg-Asp bond. To 
be sure that all other peptide bonds except Arg-Asp were inert to the action of trypsin; a 
test experiment was done prior to the cleavage of Bz-Arg. In the test experiment, trypsin 
was fed to the aqueous suspension of Z-Gly-Trp-Met-Asp(OMe)-OMe. There was no 
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change up to 36 hours which is a confirmation that trypsin indeed does not cleave any 
peptide bond in this tetrapeptide. 
  
To study the suitability of this reaction for the cleavage of Bz-Arg, TPCK treated trypsin 
was added to 5 mg protected CCK-8 suspended in water (pH around 8). As mentioned 
earlier, TPCK treated trypsin blocks the activity of α-chymotrypsin present in trypsin. 
Unlike in proteosynthesis, dilute solution is preferred for proteolysis. After 2 hours, the 
sample mixture was checked in ESIMS. Three peaks belonging to Bz-Arg-OH (Mol. 
Mass 278), H-Asp(OEt)-Tyr-Met-Gly-Trp-Met-Asp(OMe)-Phe-NH2 (Mol. Mass 1104) 
and unreacted reactant, Bz-Arg-Asp(OEt)-Tyr-Met-Gly-Trp-Met-Asp(OMe)-Phe-NH2 
(Mol. Mass 1364) were clearly seen in the ESIMS spectrum. (see figure 3.13). From 
these results it can be concluded that enzymatic removal of Bz-Arg from Bz-Arg-
Asp(OEt)-Tyr-Met-Gly-Trp-Met-Asp(OMe)-Phe-NH2 to obtain H-Asp(OEt)-Tyr-Met-
Gly-Trp-Met-Asp(OMe)-Phe-NH2 was successful. The Bz-Arg protecting group in 
contrast to Phac group proved to be useful in longer peptide sequences. The enzymatic 
removal of the protecting group from protected CCK-8 is a significant improvement 
because in the literature of CCK-8 synthesis, either the protecting group has not been 
cleaved at all (Fite et al., 2002) or is removed via chemical way (Kullmann, 1982; Sakina 
et al., 1988; Cerovsky et al., 1988) 
  
 
 
Figure 3.13 ESIMS of reaction mixture of aqueous suspension of protected CCK-8 and 
                    TPCK trypsin at pH around 8. 
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The reaction of deprotection is elucidated in scheme 3.14 
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Scheme 3.14 Cleavage of Bz-Arg from the protected CCK-8 (Bz-Arg-Asp(OEt)-Tyr- 
                      Met-Gly-Trp-Met-Asp(OMe)-Phe-NH2) by the action of TPCK trypsin at  
                      pH 8.5. 
To be able to isolate the deprotected CCK-8 peptide, a higher amount of the protected 
peptide (15 mg) was used. Because under alkaline conditions, cyclisation in the aspartate 
residue was observed earlier, the pH of the residue was adjusted to pH 7. Cyclisation in 
Asp residue with the side chain carboxyl group protected in the form of ethyl, methyl 
ester was also reported by Bodanszky (1993a).  
 
There was no reaction at this pH up to 48 h. When the pH was increased to 8.5, the 
reactant vanished completely in 4 hours and the target product (ethyl, methyl ester of 
CCK-8) was formed in an isolated yield of 16.5%. Figure 3.14 illustrates the deprotection 
of the protected CCK-8 peptide. Figure 3.14 (a) represent the chromatogram at the end of 
the reaction and (b) represent the chromatogram of deprotected CCK-8 after purification. 
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(a) (b) 
 
Figure 3.14 N-terminal deprotection of the protected CCK-8. Asp(OEt)-Tyr-Met-Gly-   
                    Trp-Met-Asp(OMe)-Phe-NH2 before purification (a) and after purification  
                   (b). 
 
As can be seen in figure 3.14 (a), at the end of the reaction, only ca. 30% reactant 
remained unreacted and ca. 70% reactant converted to target product and Bz-Arg-OH. In 
this regard, the isolated yield should have been significantly high. However, the amount 
of the reactant taken was not enough for an efficient working up procedure. Therefore, 
the yield was low. It can be concluded that this deprotection reaction goes smoothly with 
trypsin and the yield will be far better than the present yield if the amount of reactant is 
more. 
 
An alternative approach to increase the yield could be the use of thrombin instead of 
trypsin for the cleavage of Arg-Asp bond as reported by Bodanszky (1993b). 
 
The deprotected CCK-8 after purification [3.14 (b)] was checked in ESIMS. The result is 
presented in figure 3.15. In the figure, the molecular mass of the target peptide is 1104. 
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Figure 3.15 ESIMS of Asp(OEt)-Tyr-Met-Gly-Trp-Met-Asp(OMe)-Phe-NH2. 
 
M+1 (1105) and M+23 (1127) of the target peptide in the ESIMS spectrum clearly 
demonstrates that the isolated octapeptide is absolutely pure. No other significant peaks 
except some low molecular masses can be seen in the MS spectrum. Beyond that, no 
cyclisized product could be detected; neither in HPLC (figure 3.14) nor in ESIMS (figure 
3.15). It could also be demonstrated that the Bz-Arg group is superior to other used N-
terminal protecting groups in CCK-8 syntheses, because it can be cleaved easily with 
trypsin.  
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4 Experimental section 
4.1 Apparatus 
(1) Analytical HPLC  
Pumps: 305 and M 307 and Software 712 HPLC system control software (Gilson). UV 
Detector: L-7400 (Merck Hitachi LaChrom) set to 260 nm; Column: Nucleosil C18 
(Macherey-Nagel), 5 µm, 100x2 mm.  
 
(2) Preparative HPLC  
(i) Pumps: Metering pumps Model I/III (ConstaMetric); UV Detector: Model UA-6, 
UV/Vis detector (ISCO), set to 254 nm; Column: Nucleosil C18 (Macherey-Nagel),        
7 µm, 250×8 mm. 
(ii) Pumps: 305 and M 307 and Software 712 HPLC system control software (Gilson). 
UV Detector: L-7400 (Merck Hitachi LaChrom) set to 260 nm; Column: Nucleosil C18 
(Macherey-Nagel), 7 µm, 250×8 mm.  
 
(3) Preparative chromatography (MPLC) 
Pumps: Peristaltic pump P-1 (Pharmacia Fine Chemicals) and ProMinent electronic E-
0803 pump; UV Detector: Model UA-5, Absorbance/Fluorescence detector (ISCO), set to 
254 nm; Fraction collector: Model-328 (ISCO); Column: Polygosil C18 (Macherey-
Nagel), 50-60 µm, 30×4 cm. 
 
(4) Size exclusion chromatography 
UV Detector: Model UA-5, Absorbance/Fluorescence detector (ISCO), set to 260 nm, 
Fraction collector: Model-328 (ISCO); Column: Sephadex LH 20 (Pharmacia), 25-100 
µm, 90×4 cm. 
  
(5) LC-ESIMS  
1100 Series LC/MSD Trap (Agilent); Column: Nucleosil C18 (Macherey-Nagel), 3 µm, 
30×4 mm. 
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(6) FABMS 
TSQ 70 (Finnigan MAT), positive ion mode 
 
(7) Centrifuge 
Universal 16 A (Hettich) 
 
(8) pH-Meter 
E 512 (Metrohm) 
 
(9) UV lamp 
Universal-UV-lamp (CAMAG) 
 
(10) Ultrasound 
Transsonic 310 (ELMA) 
 
(11) Ultra-pure water system 
Milli-Q plus 185 (Millipore) 
 
(12) Melting point apparatus 
Modell SMP-20 (Büchi) 
 
(13) Lypohilization machine 
Cryostat: Unicryo MC 2L-60oC (Uniequip); Vacuum pump: Type 109021 Chemvac 6 
DP-101 (ILMVAC)  
4.2 Materials 
(1) Amino acids and chemicals  
All L-amino acids were gifts from Degussa. Methionine allyl ester p-tosylate (Met-
OAl·TOS) was from Fluka. Fmoc-Gly-OH, Fmoc-Trp-OH and Fmoc-Met-OH were 
obtained from Novabiochem, Merck. Pentafluorophenol was from Merck. Benzyl 
penicillin sodium was obtained from Fluka. N-Acetyl-L-tyrosine ethyl ester was from 
Sigma. Bz-Arg-OEt·HCl and Z-Asp-Phe-NH2 were prepared by standard procedures in 
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our laboratory. 10% Pd-C was a gift from Degussa. Absolute DMF was prepared 
according to the following procedure which was published in Organikum (1996). 1.5 L 
DMF, 180 ml benzene and 70 ml water were mixed and distilled under normal pressure 
until the temperature remained constant at 153oC. After cooling down to room 
temperature, calcium hydride (10 g) was added slowly and kept overnight. After that, it 
was distilled in vacuum under nitrogen avoiding light. The vacuum was set in a way that 
the temperature of the distillation was between 60 to 80ºC. HPLC grade methanol and 
acetonitrile were obtained from Fischer chemicals. All other chemicals used were of 
analytical grade. 
 
(2) Enzymes 
Papain (EC 3.4.22.2) from Carica papaya (water-soluble, 30000 USP-U/mg using casein 
as substrate) and α-chymotrypsin (EC 3.4.21.1) from bovine pancreas (Type II, 
3xcrystallized, lyophilized powder, 350 U/mg using N-acetyl-L-tyrosine ethyl ester 
(ATEE) as substrate) were obtained from Merck. Thermolysin (EC 3.4.24.2) from 
bacillus thermoproteolyticus rokko (Protease X, lyophilized powder containing calcium 
and sodium buffer salts, 50 U/mg protein, casein assay) was from Sigma. Trypsin (EC 
3.4.21.4) from porcine pancreas (crystallized, lyophilized, 40 U/mg using N-benzoyl-L-
argininethylester (BAEE) as substrate) was obtained from Merck. TPCK treated trypsin 
(EC 3.4.21.4) from bovine pancreas (10138 U/mg) and Penicillin G Amidase (PGA) 
immobilized on Eupergit C (109 U/g) were obtained from Fluka.  
 
(3) Carriers for immobilization of enzymes 
Celite-545 (particle size 20-45 µm) was obtained from Fluka. Eupergit C and VA-
Hydroxy-Biosynth were from Roehm Pharma.  
 
(4) Materials for chromatography 
Nucleosil C18 (5 µm) and Polygosil C18 (50-60 µm) were from Macherey-Nagel. The 
HPLC columns were packed in our laboratory according to the high viscosity method. 
Silica gel plates, F254 were obtained from Merck. Sephadex LH 20 (25-100 µm) was from 
Pharmacia Fine Chemicals. 
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4.3 Chromatographic methods 
 
 (1) Analytical HPLC 
 Methanol solvent system. Eluent A: 0.05 M aqueous AcONH4 (pH 6.5), which was 
prepared from 2 M AcONH4 of the stock soltion (pH 6.5, filtered through 4 µ-frit) and 
degassed by evacuation; Eluent B: 80% MeOH/0.05 M AcONH4, which was prepared by 
mixing 25 ml 2 M AcONH4 of the stock solution, 800 ml methanol and water was added 
to make volume 1 L and degassed by evacuation. The flow rate was 0.3 ml/min.  
 
HPLC i. Isocratic eluent 40% B. 
  
HPLC ii. Isocratic eluent 90% B.  
 
HPLC iii. Gradient elution from 40% B to 55% B over 24 min. 
Time (min) % of B 
0-3.60 40 
3.60-7.50 40-55 
7.50-16.50 55 
16.50-17.20 55-40 
17.20-24.00 40 
 
 HPLC iv. Gradient elution from 40% B to 85% B over 19.50 min. 
Time (min) % of B 
0-5.00 40 
5.00-8.00 40-85 
8.00-12.00 85 
12.00-13.00 85-35 
13.00-16.00 35 
16.00-17.00 35-40 
17.00-19.50 40 
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HPLC v. Gradient elution from 50% B to 70% B over 14 min 
Time (min) % of B 
0-4.00 50 
4.00-5.00 50-70 
5.00-10.00 70 
10.00-11.00 70-50 
11.00-14.00 50 
 
HPLC vi. Gradient elution from 50% B to 85% B over 19.50 min 
Time (min) % of B 
0-5.00 50 
5.00-8.00 50-85 
8.00-12.00 85 
12.00-13.00 85-45 
13.00-16.00 45 
16.00-17.00 45-50 
17.00-19.50 50 
 
HPLC vii. Gradient elution from 55% B to 85% B over 22 min 
Time (min) % of B 
0-4.00 55 
4.00-7.00 55-85 
7.00-11.50 85 
11.50-12.50 85-50 
12.50-13.51 50 
13.51-14.50 50-55 
14.50-22.00 55 
 
Acetonitrile solvent system. Eluent A: 0.1% aqueous TFA which was degassed by 
evacuation; Eluent B: 80% ACN/0.1% TFA, which was prepared by mixing 1 ml TFA, 
800 ml ACN and water was added to make the volume 1 L and degassed by evacuation. 
The flow rate was 0.3 ml/min. 
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HPLC i. Gradient elution from 35% B to 60% B over 19.50 min 
Time (min) % of B 
0-4.30 35 
4.30-5.50 35-60 
5.50-13.00 60 
13.00-14.20 60-35 
14.20-19.50 35 
 
HPLC ii. Gradient elution from 40% B to 85% B over 19.50 min 
Time (min) % of B 
0-5.00 40 
5.00-8.00 40-85 
8.00-12.00 85 
12.00-13.00 85-35 
13.00-16.00 35 
16.00-17.00 35-40 
17.00-19.50 40 
 
HPLC iii. Gradient elution from 50% B to 85% B over 19.50 min 
Time (min) % of B 
0-5.00 50 
5.00-8.00 50-85 
8.00-12.00 85 
12.00-13.00 85-45 
13.00-16.00 45 
16.00-17.00 45-50 
17.00-19.50 50 
 
(2) Preparative HPLC 
Methanol solvent system. Eluent A: 0.05 M aqueous AcONH4 (pH 6.5); Eluent B: 80% 
MeOH/0.05 M AcONH4. The flow rate was 4 ml/min. 
 
Acetonitrile solvent system. Eluent A: 0.1% aqueous TFA; Eluent B: 80% ACN/0.1% 
TFA. The flow rate was 4 ml/min. 
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(3) MPLC 
The substance to be separated in MPLC was dissolved in particular percentage of 
aqueous methanol. The particular percentage of aqueous methanol was prepared as 
written in individual steps. The eluent was 20 to 80% methanol containing 0.05 M 
AcONH4. In all cases, the starting percentage of the eluent was same to that of sample 
prepared. The concentration of the eluent was changed depending upon the elution of the 
product. The flow rate was 5 ml/min. 
 
(4) Size exclusion chromatography 
Eluent. MeOH. The flow rate was 5 ml/min. 
 
(5) Thin layer chromatography 
TLC i. n-Butanol/acetic acid/water 3:1:1 (v/v/v) 
TLC ii. Dichloromethane/methanol 7:3 (v/v) 
TLC iii. Dichloromethane/methanol 9:1 (v/v) 
Spots were detected as follows: 
UV-Test. The UV active substances were detected at 254 nm with the UV lamp. 
 
Ninhydrin reaction. 1.5 g ninhydrin and 15 ml acetic acid were mixed in 450 ml ethanol. 
The solution was sprayed on the plates and heated to 110oC. Free amino group of 
protected amino acids or of peptides showed violet spots. 
 
Chlorine/tolidine reaction. This test was performed according to the procedure published 
by Pataki (1996). The tolidine solution was prepared by dissolving 240 mg tolidine, 2 g 
potassium iodide in 69 ml acetic acid and then the volume was brought to 1000 ml with 
water. The plates were exposed to chlorine gas for about 5 minutes. After about 5 
minutes, the tolidine solution was sprayed on these plates. The protected amino acids and 
the peptides showed greenish yellow colour. 
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4.4 Enzyme immobilization 
The rotation during the immobilization refers to mixing in a covered glass bottle held by 
a clamp which was rotated with a horizontally mounted stirrer motor as shown in figure 
4.1. 
 
Wherever the immobilized enzyme was used, the rotation refers to the mixing as 
described above. This type of mixing prevents the polymer from damage. 
 
(1) Immobilization of trypsin 
Immobilizing trypsin on Eupergit C. 1 g Eupergit C washed with 1 M KH2PO4 buffer 
(pH 7.5) was added to the solution of 300 mg trypsin in 10 ml 1 M KH2PO4 buffer (pH 
7.5). After rotating for 24 hours, the solvent was sucked off and the immobilisate was 
washed with water before storing at -20oC. 
 
(2) Immobilization of α-chymotrypsin 
Adsorbing α-chymotrypsin on Celite-545. The solution of 100 mg α-chymotrypsin in 15 
ml water and 15 ml 0.05 M Tris-HCl buffer (pH 9.0) was mixed with 10 g Celite-545 
rods. After thorough mixing for 24 hours, the suspension was lyophilized and stored at -
20oC.  
 
Immobilizing α-chymotrypsin on Eupergit C. 10 g Eupergit C washed with 1 M KH2PO4 
buffer (pH 8.0) were added to the solution of 600 mg α-chymotrypsin in 100 ml 1 M 
KH2PO4 buffer (pH 8.0). After rotating for 3 days, 100 ml 1 M NaCl were added to the 
suspension. The solvent was sucked off and the α-CHY/Eupergit C was washed with 0.05 
M KH2PO4 buffer (pH 8.0) and stored at -20oC.   
        Figure 4.1 Rotating apparatus during the use of immobilized enzyme  
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(3) Immobilization of papain 
Adsorbing papain on Celite-545. The solution of 60 mg papain in 30 ml water was 
mixed with 2 g Celite-545 rods. After thorough mixing for 24 hours, the suspension was 
lyophilized and stored at -20oC.  
 
Immobilizing papain on VA-Epoxy. Prior to the immobilization of papain on VA-Epoxy, 
the VA-Hydroxy polymer had to be epoxidised. 6 g VA-Hydroxy-Biosynth suspended in 
60 ml epichlorohydrin were refluxed for 4 hours, and then sucked and washed with 
acetone. The resulting VA-Epoxy was stored at -20oC.  
 
4 g VA-Epoxy washed first with water and then with 1 M KH2PO4 buffer (pH 7.5) were 
suspended in 40 ml 1 M KH2PO4 buffer (pH 7.5). To this solution, 800 mg papain were 
added and mixed for 24 hours. It was filtered and the immobilisate was washed with 
water and stored at -20oC.  
 
4.5 Activity test of immobilized enzymes 
The activity of the enzyme was determined as µmol conversion of test substrate per mg 
immobilized enzyme after one hour reaction time. The conversion rates were not the 
same throughout the reaction time. The rates were higher at the beginning of the reaction 
and lower after some time. Therefore, one hour was used as a reference time at which all 
the conversions were calculated. 
 
(1) Trypsin-immobilisate 
Activity test. To the solution of 62 mg Bz-Arg-OEt·HCl in 1 ml 0.5 M KH2PO4 (pH 7.5), 
100 mg trypsin/Eupergit C were added. Aliquots (10 µl) were withdrawn from the 
reaction mixture at different times from 0 min to 120 min and analyzed by HPLC i 
(methanol system).  
Activity of trypsin-immobilisate. 
Trypsin/ Eupergit C (300 mg/g) (fresh): 1.81 µmol·h-1·mg-1 
Trypsin/ Eupergit C (300 mg/g) (after the first application): 1.72 µmol·h-1·mg-1 
Trypsin/ Eupergit C (300 mg/g) (after the second application): 1.26 µmol·h-1·mg-1 
Trypsin/ Eupergit C (300 mg/g) (after the third application): 1.08 µmol·h-1·mg-1 
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(2) α-Chymotrypsin-immobilisate  
Activity test. To 0.5 ml of the test solution (20 mg Ac-Tyr-OEt in 2 ml 0.01 M Tris-HCl 
buffer (pH 8.1)), 20 mg immobilized α-chymotrypsin were added. Aliquots (10 µ l) 
were withdrawn from the reaction mixture at different times from 0 min to 100 min and 
analyzed by HPLC i (methanol system).  
 
Activity of α-chymotrypsin-immobilisate. 
α-CHY/Celite-545 (10 mg/g)(fresh): 3.98 µmol·h-1·mg-1 
α-CHY/Eupergit C (60 mg/g)(fresh): 3.58 µmol·h-1·mg-1 
 
(3) Papain-immobilisate 
Activity test. To 0.5 ml test solution (300 mg Bz-Arg-OEt·HCl in 5 ml 0.5 M KH2PO4 
buffer (pH 6.0), 1 mg EDTA and 100 µl mercaptoethanol), 50 mg immobilized papain 
were added. Aliquots (10 µl) were withdrawn from the reaction mixture at different times 
from 0 min to 120 min and analyzed by HPLC i (methanol system). 
  
Activity of papain-immobilisate. 
Papain/Celite-545 (30 mg/g) (fresh): 10.51 µmol·h-1·mg-1 
Papain/VA-Epoxy (200 mg/g) (fresh): 11.03 µmol·h-1·mg-1 
 
(4) PGA/Eupergit C 
Activity test. To the solution of 6 mg benzylpenicillin-Na in 0.5 ml 1 M KH2PO4 buffer 
(pH 7.5), 50 mg PGA/Eupergit C were added. Aliquots (10 µl) were withdrawn from the 
reaction mixture at different times from 0 min to 30 min and analyzed by HPLC i 
(methanol system). 
 
Activity of PGA/Eupergit C. 
PGA/Eupergit C (120 U/g): 0.36 µmol·h-1·mg-1 
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4.6 Preparation of amino acid derivatives 
(1) Preparation of Bz-Arg-OH (Bergmann, M. and Zervas, L., 1932; Greenstein J. P. 
and Winitz M., 1961) 
To a stirred and ice cooled solution of 0.3 mol arginine dissolved in 250 ml water and 80 
ml ether, 35 ml benzoylchloride and 150 ml 2 M NaOH were added dropwise 
simultaneously. The pH of the system should be around 11. At the end of the reaction, 
crystallization of the product started. The product (Bz-Arg-OH) was recrystallized in ca. 
800 ml water containing a drop of ammonia solution (m. p. 284-286ºC, yield 47%, tR 
1.94 min in HPLC iv (methanol system), Rf 0.34 in TLC i). 
 
(2) Preparation of Phac-Gly-OH 
To a stirred solution of 0.26 mol amino acid in 260 ml 2 M NaOH, 35 ml (0.26 mol) 
phenylacetylchloride and 65 ml 4 M NaOH were added dropwise simultaneously within 1 
hour. After 2 hours, the reaction mixture was acidified with 6 M HCl to pH 2 in an ice-
bath. The product was precipitated, filtered and recrystallized in methanol (m. p.  139-
141 ºC, yield 53.3%, tR 1.22 min in HPLC vii (methanol system), Rf 0.69 in TLC i). 
 
(3) Preparation of the methyl and ethyl ester hydrochlorides of tyrosine, 
tryptophan, methionine, aspartic acid, phenylalanine, phenylacetyl glycine and 
benzoyl arginine (Brenner et al., 1950; Fles and Markovac-Prpic, 1957) 
To a stirred solution of 0.15 mol amino acid or Phac-Gly or Bz-Arg in 300 ml absolute 
MeOH (or EtOH) cooled at -5oC ( for Bz-Arg, -25º C) , 73 ml (1 mol) thionyl chloride 
were added dropwise and the reaction temperature was kept below 0oC. After adding two 
third thionyl chloride, another 100 ml MeOH were added to the reaction mixture. When 
all thionyl chloride was added, the reaction mixture was kept at room temperature 
overnight. The mixture was concentrated in vacuum and the crude product was dissolved 
in 150 ml MeOH (or EtOH), and then the MeOH (or EtOH) was removed completely. 
For synthesizing the diester of aspartic acid, another 73 ml (1 mol) of thionyl chloride 
were added dropwise to the residue dissolved in 200 ml MeOH (or EtOH) at -5oC and the 
above procedure was repeated. After removing the solvent, MeOH (or EtOH) (3x150 ml) 
was added into the residue and removed in vacuo. At the end, recrystallization was 
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performed in MeOH (or EtOH)/ diethyl ether. The crystals were filtered and washed with 
diethyl ether and dried in vacuo. The yield and analytical data are given in table 4.1 
 
Table 4.1 Isolated yields and analytical data of Tyr, Trp, Met, Asp, Phe, Phac-Gly and  
                 Bz-Arg derivatives. 
Derivative Isolated 
yield (%) 
m. p.[ºC] HPLC (MeOH system), 
tR [min] 
TLC i, 
Rf 
Tyr-OMe·HCl 88.9 178-180 HPLC iii/ 2.5 0.53 
Trp-OMe·HCl 78.3 210-212 HPLC vii/ 3.45 0.55 
Met-OEt·HCl 91.2 82-84 UV-inactive 0.63 
Asp(OEt)OEt·HCl 80.0 104-106 UV-inactive 0.54 
Phe-OMe·HCl 93.7 158-160 HPLC vii/ 3.44 0.57 
Phac-Gly-OMe 65.3 81-83 HPLC vii/ 2.30 0.81 
Bz-Arg-OEt·HCl 89.0 131-133 HPLC iv/ 6.39 0.38 
 
(4) Preparation of free amino acid ester by removing hydrochloride  
To 1.4 g (5 mmol) of Na2CO3·10H2O in 20 ml water in an ice-bath, 10 mmol of the 
hydrochloride amino acid ester were added in portions. The mixture was stirred for 15 
min at a pH, which was above 8. It was extracted with CH2Cl2 (3x15 ml). The organic 
layer was washed with saturated NaCl, dried over anhydrous Na2SO4 and concentrated in 
vacuo at 30oC. The free amino acid ester was used as soon as it was prepared. 
 
(5) Preparation of Phe-NH2·HCl 
Ammonia gas was passed through a stirred solution of 65 g (0.3 mol) Phe-OMe·HCl in 
342 ml absolute MeOH, cooled to -5oC. After saturation the solution was kept at room 
temperature overnight. Then the solvent was removed in vacuo. The residue was 
dissolved in 2 M HCl as far as possible. After removal of the solvent in vacuo, water was 
added to the residue again. The crude product was obtained after removing the solvent in 
vacuo and recrystallization was performed in EtOH (m. p. 230-233ºC, yield 85%, tR 1.50 
min in HPLC vii (methanol system), Rf 0.54 in TLC i).   
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(6) Preparation of Phac-Gly-OCam 
Phac-Gly-OH (5.0 g, 26 mmol) was dissolved in 50 ml MeOH/water (4:1) and 20 ml of 
20% aqueous Cs2CO3 were added dropwise in 1 h. The solution was evaporated to 
dryness under vacuum (bath temperature<45oC) and the residue was evaporated 3 times 
with 50 ml toluene each time. The white crystals (Phac-Gly-OCs) were dried overnight 
under high vacuum. The cesium salt was dissolved in 60 ml absolute DMF. In this 
solution α-chloroacetamide (3.5 g, 37.5 mmol) was added. After the mixture was stirred 
for 4 days at 35oC, the solution was evaporated to dryness under vacuum. The residue 
was dissolved in 100 ml EtOAc, washed with water (3x100 ml), 5% (w/v) NaHCO3 
(3x25 ml) and saturated NaCl solution (3x100 ml), dried over anhydrous Na2SO4 and 
finally evaporated to dryness under vacuum. Plac-Gly-OCam was obtained as a white 
solid (m. p. 128-130ºC, yield 85.6%, tR 1.88 min in HPLC vii (methanol system), Rf 0.56 
in TLC i).  
 
(7) Preparation of Asp(OMe)-OH·HCl 
To 208 ml absolute MeOH, cooled to -10oC, 31 ml SOCl2 and 40 g (0.3 mol) aspartic 
acid were added. A clear solution was obtained on slowly warming to room temperature. 
After standing 25 min at room temperature, 600 ml absolute ether were added. After 
cooling in an ice-bath, the precipitate was filtered off and recrystallized with 
methanol/ether containing a small amount of HCl (m. p. 193-195ºC, yield 66.0%, UV-
inactive in HPLC, Rf  0.28 in TLC i). 
 
(8) Preparation of Z-Asp(OMe)-OH  
9.6 g (52.3 mmol) Asp(OMe)-OH·HCl were dissolved in a solution of 90 ml water, 12 ml 
4 M NaOH (48 mmol) and 8.7 g (103 mmol) NaHCO3. Under stirring at room 
temperature, 66.6 mmol benzylchloroformate were added over 2 hour period. Then 4 M 
NaOH was added and the pH was kept at 8 via a pH stat. The reaction was finished when 
no more NaOH was consumed. The mixture was extracted with ether (3x20 ml) and the 
ether extracts were discarded. The aqueous phase was acidified to pH 2.0 with 
concentrated HCl, and then extracted with EtOAc (3x50 ml). The combined EtOAc 
layers were washed with water (2x20 ml), dried over anhydrous Na2SO4 and concentrated 
in vacuo. 
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The residue was recrystallized with EtOAc/PE (m. p. 95-96ºC, yield 65.1%, tR 2.06 min 
in HPLC vii (methanol system), Rf 0.64 in TLC i). 
 
(9) Preparation of Fmoc-Gly-OPfp, Fmoc-Trp-OPfp and Fmoc-Met-OPfp 
To a stirred, ice-cold solution of the Fmoc-amino acid (20 mmol) and pentafluorophenol 
(20 mmol) in 80 ml EtOAc containing 20 ml DMF or 100 ml EtOAc, 
dicyclohexylcarbodiimide (20 mmol) was added and stirring was continued for 1 hour at 
0oC and for 1 hour at room temperature. Dicyclohexylurea was filtered off and the 
solvent was evaporated in vacuo at 40oC. The residue was recrystallized in EtOAc/PE 
(for Fmoc-Trp-OPfp, Fmoc-Met-OPfp) or EtOAc (for Fmoc-Gly-OPfp). The yield and 
analytical data are given in table 4.2. The products were verified by FABMS. 
 
Table 4.2 Isolated yields and analytical data of pentafluorophenyl esters of Fmoc-Gly,    
                  Fmoc-Trp and Fmoc-Met. *HPLC was performed with methanol system. 
Derivative Isolated 
yield (%) 
m. p. 
[ºC] 
tR [min] 
HPLC* 
FABMS Rf, 
TLC i 
Fmoc-
Gly-OPfp 
91.4 146-148 1.99/HPLC ii m/z 464.0 [M+H+], 
C23H14F5N1O4 requires 
463 
0.82 
Fmoc-
Trp-OPfp 
92.4 174-176 3.66/HPLC ii m/z 593.0 [M+H+],  
C32H21F5N2O4 requires 
592.5 
0.91 
Fmoc-
Met-OPfp 
96.8 98-100 3.20/HPLC iii m/z 537.9 [M+H+], m/z 
560 [M+Na+] 
C26H20F5N1O4S1 requires 
537 
0.85 
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4.7 Synthesis of peptides 
 
4.7.1 Enzymatic synthesis of peptides 
During the synthesis of the peptides mentioned below, the progress of each reaction was 
monitored by RP-HPLC. The reaction was stopped at its kinetic optimum. Melting point 
was noted only for the peptides which crystallized and the decomposition point of 
lyophilized product has no significance for characterizing the product. 
 
(1) Synthesis of Bz-Arg-Asp(OEt)-OEt 
The synthesis of this dipeptide was carried out under solvent free conditions. 2.052 g (6 
mmol) Bz-Arg-OEt·HCl, 2.7 g (12 mmol) Asp(OEt)-OEt·HCl, 0.8 g (2.8 mmol) 
Na2CO3·10H2O, 0.8 g (7.6 mmol) Na2CO3 and 0.34 g (8.4 mmol) NaOH were mixed. 4 g 
trypsin/Eupergit C were added and stirred manually every 20 min. The reaction was 
monitored by HPLC iv (methanol system). When the reaction was finished, the mixture 
was diluted with 15 ml 80% ethanol containing 2 ml acetic acid. The pH of the system 
was around 7. This suspension was transferred to a sintered glass frit and washed with 
80% EtOH until the product was extracted completely. The filtrate was evaporated to 
dryness under vacuum. The residue left after removal of the solvent was dissolved in 
40% aqueous methanol and separated by MPLC. The pooled fractions of Bz-Arg-
Asp(OEt)-OEt were lyophilized twice yielding a white powder (1.925 g, 71.5%, tR 11.83 
min in HPLC iv (methanol system), Rf 0.55 in TLC i). 
 
(2) Synthesis of Bz-Arg-Asp(OEt)-OH using trypsin 
85 mg (0.25 mmol) Bz-Arg-OEt·HCl and 115 mg (0.5 mmol) Asp(OEt)-OEt·HCl were 
dissolved in 1.5 ml water containing 100 µl 0.5 M phosphate buffer (pH 8.0). To this 
solution, 60 mg trypsin/Eupergit C were added and the mixture was rotated for 5 hours. 
The reaction was monitored by HPLC iv (methanol system). The reactant completely 
vanished in 5 hours and the mixture was filtered to remove the immobilized trypsin. The 
immobilisate was washed with 80% EtOH until the product was extracted completely. 
The combined filtrates were concentrated in vacuo and the residue was dissolved in 35 % 
aqueous MeOH and separated by MPLC. The pooled fractions were lyophilized twice 
yielding a white powder of Bz-Arg-Asp(OEt)-OH ( 43 mg, 41.18%, tR 3.67 min in HPLC 
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iv (methanol system), FABMS m/z 422.2 [M+H+], m/z 444.2 [M+Na+], C19H27N5O6 
requires 421.4). 
 
(3) Synthesis of Bz-Arg-Asp(OEt)-OH using α-chymotrypsin 
220 mg (0.49 mmol) Bz-Arg-Asp(OEt)-OEt were dissolved in 2.4 ml ACN containing 1 
ml 0.1 M Tris-HCl buffer (pH 8.1). To this solution, 120 mg α-CHY/Celite-545 were 
added and rotated at room temperature. The reaction was monitored by HPLC iv 
(methanol system). At 65 hours, the reaction was stopped and α-CHY/Celite-545 was 
removed by filtration. The filter cake was washed with water until the product was 
transferred completely to the filtrate. The combined filtrates were concentrated in vacuo 
and the residue was dissolved in 35% MeOH and separated by MPLC. The pooled 
fractions of Bz-Arg-Asp(OEt)-OH were lyophilized twice yielding a white powder (80 
mg, 38.8%).  
 
(4) Synthesis of Bz-Arg-Asp(OEt)-Tyr-OH 
450 mg (1.0 mmol) Bz-Arg-Asp(OEt)-OEt, 350 mg (1.5 mmol) Tyr-OMe·HCl, 1.0 g (10 
mmol) KHCO3, 75 mg (0.25 mmol) Na2SO4·10H2O, 50 µl EDTA and 60 µl β-
mercaptoethanol were mixed. Free papain (80 mg) was added and stirred manually every 
20 min. The reaction was monitored by HPLC iii (methanol system). When the reaction 
was finished, 20 ml water was added to the mixture, transferred to a sintered glass frit and 
washed with water until the filtrate was neutral. The remaining filter cake was washed 
with pure methanol and the filtrate was collected. The filtrate was evaporated to dryness 
under vacuum. The obtained residue was dissolved in 35% aqueous methanol and 
separated by MPLC. The pooled fractions of Bz-Arg-Asp(OEt)-Tyr-OH were lyophilized 
twice yielding a white powder (179 mg, 30.5%, tR 7.0 min in HPLC iii (methanol 
system), FABMS m/z 585.2 [M+H+], m/z 607.2 [M+Na+], C28H36N6O8 requires 584.6).  
  
By-products were isolated and characterized by FABMS as Bz-Arg-Asp(OEt)-Tyr-Tyr-
OH (13 mg, 1.7%, tR 9.0 min in HPLC iii (methanol system), FABMS m/z 748.2 [M+H+], 
m/z 770.3 [M+Na+], C37H45N7O10 requires 747.8) and Bz-Arg-Asp(OEt)-Tyr-Tyr-Tyr-
OH (tR 11.0 min in HPLC iii (methanol system), FABMS m/z 911.5 [M+H+], m/z 933.7 
[M+Na+], C46H54N8O12 requires 910.9).  
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 (5) Synthesis of Bz-Arg-Asp(OEt)-Tyr-OH from Bz-Arg-OEt·HCl without isolating 
the intermediate 
1.026 g (3 mmol) Bz-Arg-OEt·HCl, 1.350 g (6 mmol) Asp(OEt)-OEt·HCl, 400 mg (3.8 
mmol) Na2CO3, 400 mg Na2CO3·10 H2O (1.4 mmol), 170 mg NaOH (4.2 mmol) and 300 
mg trypsin/Eupergit C were mixed under solvent free conditions. The reaction was 
monitored by HPLC iv (methanol system). When the highest HPLC yield was obtained, 
the reaction was stopped and the mixture was diluted with 15 ml 80% ethanol. The 
immobilized trypsin was removed by filtration and the immobilisate was washed with 
80% EtOH until the product was extracted completely. The filtrate was concentrated 
under vacuum. The solid left after concentration was used for the next coupling. To this 
solid, 700 mg (3 mmol) Tyr-OMe·HCl, 4 g KHCO3 (40 mmol), 1.150 g Na2CO3·10H2O 
(4 mmol), 100 µl EDTA, 120 µl β-mercaptoethanol and 200 mg free trypsin were mixed 
under solvent free conditions. The reaction was checked in HPLC iii (methanol system). 
When the reaction was finished, 20 ml water were added to the mixture, transferred to a 
sintered glass frit and washed with water until the filtrate was neutral. The filter cake was 
washed with pure methanol and the filtrate was collected. The filtrate was evaporated to 
dryness under vacuum. The remaining residue was dissolved in 35% aqueous methanol 
and separated by MPLC. The pooled fractions of Bz-Arg-Asp(OEt)-Tyr-OH were 
lyophilized twice yielding a white powder (460 mg, 26.2%). 
 
(6) Synthesis of Bz-Arg-Asp(OEt)-Tyr-Met-OH 
234 mg (0.4 mmol) Bz-Arg-Asp(OEt)-Tyr-OH and 428 mg (2 mmol) Met-OEt·HCl were 
dissolved in 4 ml 0.1 M Tris-HCl buffer (pH 8.1) containing 400 µl ACN. To this 
solution, 50 mg free α-chymotrypsin were added and thoroughly mixed by rotation. The 
reaction was monitored by HPLC v (methanol system). The highest HPLC yield (39.3%) 
was obtained after 5 h 30 min. The reaction was stopped by adding few drops of acetic 
acid. The mixture was filtered and washed with methanol. The filtrate was evaporated to 
dryness under vacuum. The residue was dissolved in 40% aqueous methanol and 
separated by MPLC. The pooled fractions were lyophilized twice yielding a white 
powder of Bz-Arg-Asp(OEt)-Tyr-Met-OH (111 mg, 38.7%, tR 9.11 min in HPLC v 
(methanol system), FABMS m/z 716.3 [M+H+], m/z 738.2 [M+Na+], C33H45N7O9S1 
requires 715.8). 
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The unreacted Bz-Arg-Asp(OEt)-Tyr-OH was also collected from the MPLC fractions, 
lyophilized and used again in this reaction. By this procedure, another 47 mg of the 
product (Bz-Arg-Asp(OEt)-Tyr-Met-OH) were obtained and the isolated yield increased 
to 55.1%. 
 
(7) Synthesis of Bz-Arg-Asp(OEt)-Tyr-Met-OAl 
180 mg (0.3 mmol) Bz-Arg-Asp(OEt)-Tyr-OH and 272 mg (0.75 mmol) Met-OAl·PTS 
were dissolved in 8 ml ACN containing 300 µl 0.1 M Tris-HCl buffer (pH 8.1). To this 
solution, 500 mg α-CHY/Celite-545 were added and the mixture was rotated. The 
reaction was monitored by HPLC i (acetonitrile system). After 47 hours, the reaction was 
stopped by adding a few drops of acetic acid and was filtered to remove α-CHY/Celite-
545. The filter cake was washed with pure methanol. The filtrate was collected and 
evaporated to dryness under vacuum. The residue was dissolved in 45% aqueous 
methanol and separated by MPLC. The pooled fractions were lyophilized yielding a 
white powder of Bz-Arg-Asp(OEt)-Tyr-Met-OAl (290 mg, 63.9%, tR 10.09 min in 
HPLCi 
(acetonitrile system), FABMS m/z 756.2 [M+H+], m/z 778.2 [M+Na+], C36H49N7O9S1 
requires 755.9).  
 
(8) Cleavage of Bz-Arg from Bz-Arg- Asp(OEt)-Tyr-Met-OH 
72 mg (0.1 mmol) Bz-Arg-Asp(OEt)-Tyr-Met-OH were suspended in 3.5 ml water and 
the pH was adjusted to 7.6 by 1 M NaOH. To this suspension, 60 mg trypsin/Eupergit C 
were added and thoroughly mixed by rotation. The reaction was checked in HPLC iv 
(methanol system). There was no increase in the HPLC yield of the product after 22 h. At 
48 h, the reaction was stopped by adding few drops of acetic acid. The mixture was 
filtered and the filter cake was washed with 80% methanol thoroughly. The filtrate was 
evaporated to dryness under vacuum. The left residue was dissolved in 27% aqueous 
methanol and separated by MPLC. The pooled fractions were lyophilized twice yielding 
a white powder of Asp(OEt)-Tyr-Met-OH (30 mg, 65.6%, tR 2.30 min in HPLC iv 
(methanol system), FABMS m/z 456.1 [M+H+], m/z 477.9 [M+Na+] C20H29N3O7S1 
requires 455.5). 
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(9) Synthesis of Phac-Gly-Trp-OMe  
This dipeptide was synthesized according to the method described by Xiang et al., 2004. 
125 mg (0.5 mmol) Phac-Gly-OCam and 164 mg (0.75 mmol) H-Trp-OMe were 
dissolved in 50 ml EtOAc containing 270 µl 0.2 M borax buffer (pH 8.5), 30 µl β-
mercaptoethanol, and 1 mg EDTA. To this solution 300 mg papain/VA-Epoxy were 
added and thoroughly mixed by rotation. After 3 hours the reaction was complete and the 
HPLC yield was 95% in HPLC vii (methanol system). The mixture was filtered to 
remove the immobilized enzyme which was washed with a mixture of 40 ml ethyl acetate 
and 10 ml water. The combined filtrates were extracted successively with 1M citric acid 
(3x100 ml), 5% NaHCO3 (3x100 ml), and saturated sodium chloride (1x100 ml). The 
organic phase was dried over anhydrous Na2SO4 and concentrated under vacuum. The 
residue was lyophilized yielding a white solid of Phac-Gly-Trp-OMe (177 mg, 90.0%, m. 
p. 126-128ºC, tR 10.30 min in HPLC vii (methanol system)).  
 
(10) Cleavage of Phac from Phac-Gly-Trp-OMe 
120 mg (0.3 mmol) Phac-Gly-Trp-OMe and 250 mg PGA/Eupergit C were suspended in 
water and the pH was adjusted to 6.0 with 1 M HCl. The mixture was rotated. The 
reaction was monitored in HPLC vi (methanol system) and was stopped after 24 hours. 
The mixture was filtered to remove the immobilized enzyme and the filter cake was 
washed with 80% ethanol. The filtrate was evaporated to dryness under vacuum. The 
residue was dissolved in 45% aqueous methanol and separated by MPLC. The pooled 
fractions were lyophilized yielding a white solid (30 mg, 36.3%, tR 5.72 min in HPLC vi 
(methanol system), FABMS m/z 276.2 [M+H+], m/z 298.1 [M+Na+], C14H17N3O3 
requires 275.3). The results caused by pH change during the cleavage of Phac from Phac-
Gly-Trp-OMe are mentioned in table 3.1 
 
(11) Investigations of the synthesis of Bz-Arg-Asp(OEt)-Tyr-Met-Gly-Trp-OMe 
Bz-Arg-Asp(OEt)-Tyr-Met-OH/OAl and Gly-Trp-OMe were stirred in different reaction 
conditions in presence of different enzymes but no product could be observed. The detail 
conditions and the amount of acyl donor and nucleophile are presented in table 4.3. 
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Table 4.3 Conditions employed during the investigation of synthesis of Bz-Arg- 
                 Asp(OEt)-Tyr-Met-Gly-Trp-OMe; Tris-HCl buffer was 0.1 M (pH 8.1) and  
                 borax buffer was 0.1M (pH 6.9). 
Reactants Reaction media Catalyst HPLC 
yield 
Bz-Arg-Asp(OEt)-Tyr-Met-OH: 35 mg 
Gly-Trp-OMe: 20 mg 
ACN: 300 µl 
Tris-HCl: 600 µl 
10 mg 
α-CHY 
0 
Bz-Arg-Asp(OEt)-Tyr-Met-OH: 22 mg 
Gly-Trp-OMe: 42 mg 
ACN: 600 µl 
Borax: 5 µl ;EDTA: 5 µl 
β-mercaptoethanol: 5 µl 
300mg 
Papain/VA-Epoxy 
0 
Bz-Arg-Asp(OEt)-Tyr-Met-OH: 22 mg 
Gly-Trp-OMe: 12 mg 
Na2CO3·10 H2O: 20 mg 
KHCO3: 25 mg 
EDTA: 5 µl 
Β-mercaptoethanol: 5 µl 
8 mg papain 0 
Bz-Arg-Asp(OEt)-Tyr-Met-OH: 22 mg 
Gly-Trp-OMe: 12 mg 
Na2CO3·10 H2O: 20 mg 
KHCO3: 25 mg 
 
8 mg α-CHY 0 
Bz-Arg-Asp(OEt)-Tyr-Met-OAl: 19 mg 
Gly-Trp-OMe: 28 mg 
ACN: 2 ml 
Tris-HCl: 15 µl 
100 mg α- 
CHY/Celite-545 
 
Bz-Arg-Asp(OEt)-Tyr-Met-OAl: 19 mg 
Gly-Trp-OMe: 28 mg 
ACN: 1 ml 
Tris-HCl: 1 ml 
50 mg α-
CHY/Celite-545 
0 
Bz-Arg-Asp(OEt)-Tyr-Met-OAl: 19 mg 
Gly-Trp-OMe: 28 mg 
EtOAc: 2.5 ml 
Borax buffer: 15 µl 
Et3N: 25 µl 
50 mg α-
CHY/Celite-545 
0 
 
In most cases, Gly-Trp-OH was formed which finally converted to diketopiperazines. 
When α-CHY was used, Bz-Arg-Asp(OEt)-Tyr-OH was formed from Bz-Arg-Asp(OEt)-
Tyr-Met-OH. Similarly, Bz-Arg-Asp(OEt)-Tyr-Met-OAl was also hydrolysed to Bz-Arg-
Asp(OEt)-Tyr-Met-OH.  
 
(12) Synthesis of Phac-Gly-Trp-Met-OEt 
The synthesis was performed under solvent free conditions. 158 mg (0.4 mmol) Phac-
Gly-Trp-OMe, 343 mg (1.6 mmol) Met-OEt·HCl, 80 mg (0.8 mmol) KHCO3 and 458 mg 
(1.6 mmol) Na2CO3·10H2O were mixed. 500 mg α-chymotrypsin/Eupergit C were added 
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and stirred manually every 20 min. The reaction was monitored in HPLC vii (methanol 
system). After the completion of the reaction, the mixture was washed with water until 
the filtrate was neutral. Most of the peptide was extracted with 100 ml 80% EtOH. The 
residue was then sonicated to extract the product completely. The combined filtrates were 
evaporated to dryness under vacuum. The tripeptide ester Phac-Gly-Trp-Met-OEt was 
obtained by recrystallization with EtOH as a white solid (135 mg, 62.7%, m. p. 172-
174ºC, tR 13.51 min in HPLC vii (methanol system)).  
 
(13) Synthesis of Phac-Gly-Trp-Met-OAl  
158 mg (0.4 mmol) Phac-Gly-Trp-OMe, 200 mg (0.55 mmol) Met-OAl·PTS, 40 mg (0.4 
mmol) KHCO3 and 35 mg (0.12 mmol) Na2CO3·10H2O were mixed. 150 mg α-
chymotrypsin/Celite-545 were added and stirred manually every 20 min. The reaction 
was monitored in HPLC ii (acetonitrile system). When the reaction was finished, the 
mixture was washed with water until pH 7.0 was reached, then was diluted with 100 ml 
warm 80% EtOH and then sonicated to extract the tripeptide. After removal of the 
immobilized enzyme by filtration, the solvent was evaporated to dryness under vacuum. 
The tripeptide ester Phac-Gly-Trp-Met-OAl was obtained by recrystallization with EtOH 
as a white solid (134 mg, 60.1%, m. p. 164-167ºC, tR 11.63 min in HPLC ii (acetonitrile 
system), FABMS m/z 551.2 [M+H+], m/z 573.1 [M+Na+], C29H34N4O5S1 requires 550). 
The effect of different salts in the yield of the product is mentioned in table 3.2. 
 
 (14) Synthesis of Z-Asp(OMe)-Phe-NH2  
4.0 g (14.2 mmol) Z-Asp(OMe)-OH and 3.68 g (18.3 mmol) H-Phe-NH2·HCl were 
suspended in 64 ml H2O and the pH was adjusted to 7.0 with 1 M NaOH. To this solution 
10 mg thermolysin were added and stirred at 40°C. After 7 hours, the reaction was 
complete. The reaction was monitored in HPLC vii (methanol system). The precipitated 
white product Z-Asp(OMe)-Phe-NH2 was isolated by filtration, washed with 5% cold 
citric acid (3x100 ml) and cold water (3x100 ml) successively. Finally, the product was 
air dried. (5.87 g, 96.8%, m. p. 180-183oC, tR 11.57 min in HPLC vii (methanol system)). 
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(15) Synthesis of Phac-Gly-Trp-Met-Asp(OMe)-Phe-NH2 
110 mg (0.2 mmol) Phac-Gly-Trp-Met-OAl and 165 mg (0.5 mmol) Asp(OMe)Phe-
NH2·HCl were dissolved in 6 ml EtOAc containing 240 µl 0.1 M borax buffer (pH 8.2), 
400 µl 0.1 M Tris-HCl buffer (pH 8.1) and 20 µl Et3N. To this solution, 600 mg α-
CHY/Celite-545 were added and rotated. The reaction was monitored in HPLC iii 
(acetonitrile system). After 95 hours, the reactant Phac-Gly-Trp-Met-OAl was completely 
converted and the HPLC yield of the target product was 66.7%. After this time, the 
concentration of the product started to decrease. The reaction was stopped by adding a 
few drops of acetic acid. The mixture was filtered and the filter cake was washed with 
80% methanol followed by EtOAc/H2O (4:1) until the product was extracted completely.  
The combined filtrates were dried under vacuum and the crude product was dissolved in 
pure methanol and separated by a Sephadex LH 20 column. Phac-Gly-Trp-Met-
Asp(OMe)-Phe-NH2  was eluted first and the pooled fractions were collected and dried 
under vacuum yielding a white solid (85 mg, 54.0%, tR 6.11 min in HPLC iii (acetonitrile 
system), FABMS m/z 786.2 [M+H+], C40H47N7O8S1 requires 785.9). The yield of the 
product obtained in different reaction systems is given in table 3.3. 
 
(16) Cleavage of Phac from Phac-Gly-Trp-Met-Asp(OMe)-Phe-NH2 
112 mg (0.2 mmol) Phac-Gly-Trp-Met-Asp(OMe)-Phe-NH2 was suspended in 10 ml 
water and the pH was adjusted to 7.6 with 1 M NaOH. After addition of 350 mg 
PGA/Eupergit C, the mixture was stirred at 35ºC for 30 hours. The reaction was 
monitored in HPLC ii (acetonitrile system). To extract the product, the mixture was 
diluted with 20 ml 80% EtOH, sonicated and filtered. The filtrate was evaporated to 
dryness. The residue was separated by preparative HPLC. The pooled fractions were 
lyophilized twice yielding white powder (9 mg, 6.7%, tR 3.85 min in HPLC i (acetonitrile 
system), FABMS m/z 668.2 [M+H+], C32H41N7O7S1 requires 667.7) 
 
(17) Cleavage of Phac and methyl ester from Phac-Gly-Trp-Met-Asp(OMe)-Phe-
NH2 
This synthesis was repeated according to the procedure reported elsewhere (Xiang et al., 
2004). The reaction was monitored in HPLC vii (methanol system). (isolated yield 
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10.8%, tR 6.72 min in HPLC vii (methanol system), FABMS, m/z 676.1 [M+Na+], 
C31H39N7O7S1 requires 653.7).  
 
(18) Synthesis of Bz-Arg-Asp(OEt)-Tyr-Met-Gly-Trp-Met-Asp(OMe)-Phe-NH2 
46 mg (0.06 mmol) Bz-Arg-Asp(OEt)-Tyr-Met-OAl and 21 mg (0.03 mmol) Gly-Trp-
Met-Asp(OMe)-Phe-NH2 were dissolved in 4 ml ACN containing 18 µl 0.05 M Tris-HCl 
buffer (pH 8.0) and 18 µl Et3N. To this mixture, 70 mg α-CHY/Eupergit C were added 
and rotated at room temperature. The reaction was monitored in HPLC ii (acetonitrile 
system). After 118 hours, the reaction was stopped and filtered to remove immobilized 
enzyme. The filter cake was washed with 80% ACN in which the solubility of reactants 
and product was higher in comparison to other solvents like MeOH, EtOH and EtOAC. 
The combined filtrates were dried in vacuum and the residue was dissolved in 50% 
MeOH and separated by MPLC. The pooled fractions were lyophilized twice yielding a 
white solid (7 mg, 17.1%, tR 11.02 min in HPLC ii (acetonitrile system), FABMS m/z 
1365.4 [M+H+], C65H84N14O15S2 requires 1364). The effect of different reaction media 
and different enzyme carriers in the yield of the product is given in table 3.4. 
 
(19) Cleavage of Bz-Arg from Bz-Arg-Asp(OEt)-Tyr-Met-Gly-Trp-Met-Asp(OMe)-
Phe-NH2 
15 mg  (0.01 mmol) Bz-Arg-Asp(OEt)-Tyr-Met-Gly-Trp-Met-Asp(OMe)-Phe-NH2 were 
suspended in 3.5 ml water and pH was adjusted to 7 with 1 M NaOH. 30 mg 
trypsin/Eupergit C were added and the mixture was rotated at room temperature. The 
reaction was monitored in HPLC i (acetonitrile system). There was no reaction up to 48 
hours although more immobilized enzyme and free enzymes (TPCK treated, 2 mg) were 
added in between. Then the pH was increased to 8.5 and the reactant completely vanished 
in 4 hour after the pH was 8.5. The reaction was stopped by shifting the pH to pH 6 of the 
mixture with acetic acid. The mixture was filtered to remove enzyme. The filter cake was 
washed with 80% ACN till the product was completely transferred to the filtrate. The 
combined filtrates were evaporated to dryness under vacuum and the residue was 
dissolved in 52.5% ACN and separated by preparative HPLC in the acetonitrile system. 
The pooled fractions were lyophilized yielding a white powder (2 mg, 16.5%, tR 10.09 
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min in HPLC i (acetonitrile system), ESIMS m/z 1105.2 [M+H+], m/z 1127.4 [M+Na+], 
C52H68N10O13S2 requires 1104). 
 
4.7.2 Chemical synthesis of peptides 
4.7.2.1 Synthesis of Phac-peptides 
Phac-Gly-Trp-OMe. 20 mmol HOBt were dissolved in 50 ml anhydrous THF and 20 
mmol Phac-Gly-OH were dissolved in 60 ml DMF. After mixing these two solutions, 22 
mmol 3 M DCC in DCM were added. After stirring for 1 hour, the DCU was removed by 
filtration. The filtrate was added into a solution of 20 mmol Trp-OMe·HCl in 60 ml 
DMF. The pH was adjusted to 8 by adding N-methylmorpholine. The mixture was stirred 
overnight, filtered and evaporated in vacuo to dryness. The residue was dissolved in 200 
ml EtOAc and extracted with 1 M citric acid (3x50 ml), 10% Na2CO3 (3x50 ml) and 
saturated NaCl (3x50 ml). After drying over anhydrous Na2SO4, filtration followed by 
concentration, the residue Phac-Gly-Trp-OMe was crystallized (table 4.4). 
 
Phac-Gly-Trp-OH. To obtain Phac-Gly-Trp-OH, 7 mmol Phac-Gly-Trp-OMe were 
dissolved in water/acetone (140 ml, 1:1 v/v) and treated with 4 ml 4 M NaOH. The 
reaction was controlled by TLC i. When the reaction was completed, acetone was 
removed in vacuo. The solution was acidified with 6 M HCl to pH 3.0, extracted with 
110 ml EtOAc and washed with saturated NaCl to pH 7.0. After drying over anhydrous 
Na2SO4, filtration and concentration, Phac-Gly-Trp-OH was obtained. The yield after 
isolation and analytical data are given in table 4.4. 
 
Phac-Gly-Trp-Met-OAl. 20 mmol HOBt were dissolved in 50 ml anhydrous THF and 20 
mmol Phac-Gly-Trp-OH were dissolved in 60 ml DMF. After mixing these two solutions, 
22 mmol 3 M DCC in DCM were added. After stirring for 1 hour, the DCU was removed 
by filtration. The filtrate was added into a solution of 20 mmol Met-OAl·PTS in 60 ml 
DMF. The pH was adjusted to 8 by adding N-methylmorpholine. The mixture was stirred 
overnight, filtered and evaporated in vacuo to dryness. The residue was dissolved in 200 
ml EtOAc and extracted with 1 M citric acid (3x50 ml), 10% Na2CO3 (3x50 ml) and 
saturated NaCl (3x50 ml). After drying over anhydrous Na2SO4, filtration followed by 
concentration, the residue Phac-Gly-Trp-Met-OAl was crystallized (table 4.4). 
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Table 4.4 Solvents used for recrystallization, isolated yields and analytical data of Phac- 
                 peptides. * HPLC methanol system. ** HPLC acetonitrile system. 
Derivative Recrystalized 
in 
Isolated 
yield (%) 
m. p. 
[ºC] 
tR(min), HPLC 
system 
TLC i 
Rf 
Phac-Gly-Trp-
OMe 
EtOAc/PE 74 120-123 10.30/HPLC vii* 0.79 
Phac-Gly-Trp-OH 
 
- 90 - 3.01/HPLC vii* 0.68 
Phac-Gly-Trp-
Met-OAl 
EtOH 52 164-167 11.63/HPLC ii** 0.80 
 
 
4.7.2.2 Synthesis of the C-terminal pentapeptides   
 
(1) Hydrogenation of Z-Asp(OMe)-Phe-NH2 
4 g (9.3 mmol) Z-Asp(OMe)-Phe-NH2 were completely dissolved in 700 ml warm 
MeOH followed by addition of 1.7 ml 6 M HCl, and then 200 mg of 10% Pd-C were 
added. The mixture was divided into two parts. Half of the mixture was poured into a 500 
ml shaked-bottle and gaseous hydrogen was led in. The reaction was checked in HPLC 
vii (methanol system). The reaction was complete in 20 min. The remaining portion of 
the mixture was also hydrogenated as done before. The combined reaction mixture was 
filtered and the filtrate was concentrated in vacuo to yield a white solid of Asp(OMe)-
Phe-NH2·HCl (2.97 g, 96.4%, m. p. 155-158oC, tR 2.10 min in HPLC vii (methanol 
system)). 
 
(2) Fmoc-Met-Asp(OMe)-Phe-NH2 
To a stirred solution of Asp(OMe)-Phe-NH2·HCl (3.96 g, 12 mmol) in DMF (55 ml), 
Fmoc-Met-OPfp (6.48 g, 12 mmol) and Et3N (3.36 ml, 24 mmol) were added and stirring 
was performed for 20 min, then the solution was concentrated in vacuo. The residue was 
crystallized by trituration with ether, giving Fmoc-Met-Asp(OMe)-Phe-NH2 (7.4 g, 
95.3%, m. p. 170-171oC, tR 5.65 min in HPLC ii (methanol system), FABMS m/z 647.0 
[M+H+], m/z 669.2 [M+Na+], C34H38N4O7S1 requires 646.8). 
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(3) Fmoc-Trp-Met-Asp(OMe)-Phe-NH2 
Fmoc-Met-Asp(OMe)-Phe-NH2 (7.4 g, 11.4 mmol) was treated with  10% dimethylamine 
solution in DMF (6 ml dimethylamine + 54 ml DMF) for 10 min, then the solution was 
concentrated in vacuo. The residue was triturated with petroleum ether. Met-Asp(OMe)-
Phe-NH2 was obtained by filtration. (4.6 g, 95.1%, m. p. 148-150oC, tR 9.16 min in HPLC 
ii (methanol system), FABMS m/z 424.9 [M+H+], C19H28N4O5S1 requires 424.5). 
 
To a stirred solution of this compound (5.4 g, 12.7 mmol) in 50 ml DMF, Fmoc-Met-
OPfp (7.5 g, 12.6 mmol) and Et3N (1.82 ml, 13 mmol) were added and stirring was 
performed for 15 min, then the solution was concentrated in vacuo. The residue was 
crystallized by trituration with EtOAc, giving Fmoc-Trp-Met-Asp(OMe)-Phe-NH2 (10.0 
g, 94.6%, m.p. 182-183oC, tR 8.33 min in HPLC ii (methanol system), FABMS m/z 833.2 
[M+H+], m/z 855.5 [M+Na+], C45H48N6O8S1 requires 832.9). 
 
(4) Fmoc-Gly-Trp-Met-Asp(OMe)-Phe-NH2 
Fmoc-Trp-Met-Asp(OMe)-Phe-NH2 (9.2 g, 11.0 mmol) was treated with  10% 
dimethylamine solution in DMF (5 ml dimethyl amine + 45 ml DMF) for 20 min, then 
the solution was concentrated in vacuo. The residue was triturated with petroleum ether. 
Trp-Met-Asp(OMe)-Phe-NH2 was obtained by filtration. (6.5 g, 96.4%, decomposition at 
169oC, tR 8.91 min in HPLC ii (methanol system), FABMS m/z 611.1 [M+H+], 
C30H38N6O6S1 requires 610.7). 
 
To a stirred solution of this compound (6.1 g, 10 mmol) in DMF (50 ml), Fmoc-Gly-
OPfp (4.6 g, 10 mmol) and Et3N (1.4 ml, 10 mmol) were added and stirring was 
performed for 20 min, then the solution was concentrated in vacuo. The residue was 
crystallized by trituration with EtOAc, giving Fmoc-Gly-Trp-Met-Asp(OMe)-Phe-NH2 
(8.0 g, 89.9%, m. p. 166-170oC, tR 6.79 min in HPLC ii (methanol system), FABMS 
m/z 890.2 [M+H+], C47H51N7O9S1 requires 889.9). 
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(5) Gly-Trp-Met-Asp(OMe)-Phe-NH2 
Fmoc-Gly-Trp-Met-Asp(OMe)-Phe-NH2 (8.5 g, 9.6 mmol) was treated with 10% 
dimethylamine solution in DMF (7 ml dimethyl amine + 63 ml DMF) for 15 min, then 
the solution was concentrated in vacuo. The residue was triturated with petroleun ether, 
then filtered off to give Gly-Trp-Met-Asp(OMe)-Phe-NH2 (6.0 g). This free pentapetide 
was found impure when checked in HPLC. This crude pentapeptide was purified by 
MPLC with gradient elution of methanol starting with 50%. The concentration of 
methanol was increased depending upon the elution of the product. The first, second and 
third peak was collected, concentrated and lyophilized before carrying out the MS 
analysis. The FABMS showed that only first peak contained the free pentapeptide. When 
this pentapeptide was checked in HPLC i (acetonitrile system), the single peak in 
methanol system was resolved into four peaks. All four peaks were separated and isolated 
by preparative HPLC in the acetonitrile system with 35% B. The first peak was found to 
be pure Trp-Met-Asp(OMe)-Phe-NH2 (1.1 g, 18.8%, tR 3.70 min in HPLC i (acetonitrile 
system), FABMS m/z 611.2 [M+H+], m/z 633.3 [M+Na+], C30H38N6O6S1 requires 610.7) 
followed by pure Gly-Trp-Met-Asp(OMe)-Phe-NH2 (1.9 g, 29.6%, tR 3.85 min in HPLC i 
(acetonitrile system), FABMS m/z 668.3 [M+H+], m/z 690.0 [M+Na+], C32H41N7O7S1 
requires 667.8). The next two successive peaks were cyclic products formed by the ring 
closure of side chain of asparatic acid of both tetrapeptide (390 mg, 7.0%, tR 3.87 min in 
HPLC i (acetonitrile system), FABMS m/z 579.2 [M+H+], m/z 601.2 [M+Na+], 
C29H34N6O5S1 requires 578) and pentapeptide respectively (870 mg, 14.3% tR 3.95 min in 
HPLC i (acetonitrile system), FABMS m/z 636.1 [M+H+], m/z 658.2 [M+Na+], 
C31H37N7O6S1 requires 635).  
 
(6) Gly-Trp-Met-Asp(OH)-Phe-NH2 
Fmoc-Gly-Trp-Met-Asp(OMe)-Phe-NH2 (356 mg, 0.4 mmol) was suspended in 
water/acetone (40 ml, 1:1 v/v) and treated with 1 ml 4 M NaOH for 1 hour. Then the 
solution was concentrated in vacuo to remove acetone. The remaining solution was 
neutralized with 1 M HCl. A white solid (Gly-Trp-Met-Asp(OH)-Phe-NH2) precipitated. 
It was isolated by filtration and dried (52 mg, 19.9%, decomposition at 230oC, tR 6.73 
min in HPLC vii (methanol system), FABMS m/z 654 [M+H+], m/z 676.1 [M+Na+], 
C31H39N7O7S1requires653.7). 
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5 Summary 
 
Enzymes can be used often favorably in organic syntheses, because they can be applied at 
room or slightly elevated temperature and in aqueous phase. Therefore, enzymatic 
reactions are economically and environmentally superior to classical organic reactions. 
Moreover, many side reactions, especially racemization occurring in the chemical peptide 
synthesis can be avoided and it is not necessary to protect all the side chains of amino 
acids involved in the coupling. However, there is no general protocol available for the 
enzymatic reactions therefore each step has to be optimized taking into account substrate 
structure, concentration, reaction media, temperature and the type of protease.  
 
The target octapeptide (CCK-8) is the minimum active sequence with the same biological 
activity as naturally occurring cholecystokinin and is a potential therapeutic agent in the 
control of gastrointestinal functions. CCK-8 also acts as a neurotransmitter. 
 
The objective of this thesis is to synthesize N-terminal protected and deprotected CCK-8. 
In former investigations the enzymatically cleavable Phac group was used. But in our 
group it was found that the cleavability depends on the peptide sequence and sometimes 
can not be cleaved at all. As an alternative Bz-Arg was used as the N-terminal protecting 
group as suggested by Glass (1987). This is possible because of the high specificity of 
trypsin towards basic amino acids in the P1 position and because there is no basic amino 
acid in the target peptide sequence. This protecting group could be introduced and 
removed easily with trypsin in test peptides and also in the octapeptide. The enzymatic 
removal of Bz-Arg from protected CCK-8 is a significant improvement because in the 
literature of CCK-8 syntheses, either the protecting group (Phac) has not been cleaved at 
all (Fite et al., 2002) or is removed chemically (Kullmann, 1982; Sakina et al., 1988; 
Cerovsky et al., 1988) by using the Boc or Fmoc group. 
 
Different fragments of CCK-8 were synthesized, because it was not known in advance 
which fragment condensation will be successful. Two possible strategies were considered 
[(3+2) +3] and [3+ (2+3)]. The fragments were synthesized using enzymatic methods 
exclusively. Whenever it was possible, immobilized enzymes were applied. This is 
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important for the large scale synthesis and therapeutical application of peptides. Except 
the Asp-Tyr and Asp-Phe couplings, all other couplings were performed using 
immobilized enzymes. 
 
The catalytic mechanism of cysteine or serine proteases involves the formation of an 
acyl-enzyme complex at the transition state. It is mentioned in the literature that the acyl- 
donor needs an ester group to form the enzyme substrate complex. In contradiction with 
this statement, we had found quite often and also in this work that the free acyl-donor 
(e.g. Bz-Arg-Asp(OEt)-Tyr-OH) could couple effectively with a nucleophile (Met-
OAl·PTS) to yield the peptide (Bz- Arg-Asp(OEt)-Tyr-Met-OAl).  
 
In chemical peptide synthesis, where racemization is always a danger during the 
activation of the carboxyl component, especially in the case of peptides, the sequence is 
synthesized from the C-terminal to the N-terminal (C       N strategy). For the enzymatic 
synthesis the opposite, N       C strategy is superior. The N-terminal tripeptide fragment of 
CCK-8 (Bz-Arg-Asp(OEt)-Tyr-Met-OH/OAl) was achieved by the coupling of the 
individual amino acid derivative towards the C-terminal end of the growing peptide 
chain. This fragment was used to investigate whether the Bz-Arg group can be cleaved 
from Bz-Arg-Asp(OEt)-Tyr-Met-OH or not. The result showed that Bz-Arg could be 
removed easily from Bz-Arg-Asp(OEt)-Tyr-Met-OH with trypsin in a good isolated yield 
(65.6%). Even after a prolonged exposure of the peptide to trypsin no attack of any of the 
other peptide bonds could be detected. 
 
For the [(3+2) +3] strategy Phac-Gly-OCam and Trp-OMe were coupled. The cleavage of 
the Phac group could also be performed successfully with PGA. However, this dipeptide 
is prone for diketopiperazine formation at higher pH (>7). This side reaction could be 
suppressed completely by carrying out the reaction at pH 6. However, the 3+2 coupling 
could not be performed at this pH. On the other hand, the diketopiperazine formation at 
higher pH values exceeded by far the peptide bond formation. Therefore, the [(3+2) +3] 
strategy was interrupted at this stage. 
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For the alternative strategy [3+(3+2)], the synthesis of the tripeptide fragment Phac-Gly-
Trp-Met-OEt could be performed in analogy to Capellas et al. (1996a), however, prior to 
the coupling of Phac-Gly-Trp-OMe with Met-OEt·HCl, the dipeptide methyl ester had to 
be converted in a laborious way to the more active Cam ester. This synthesis could be 
greatly improved performing the coupling of the dipeptide methyl ester with Met-
OEt·HCl under solvent free conditions. Thus three reaction steps could be avoided. For 
the following 3+2 coupling, the tripeptide allyl ester was superior to the ethyl ester. Phac-
Gly-Trp-Met-OAl was synthesized by stepwise N       C strategy and Asp(OMe)-Phe-NH2 
was achieved by catalytic hydrogenation of Z-Asp(OMe)-Phe-NH2. The C-terminal 
pentapeptide fragment (CCK-5) was prepared by α-chymotrypsin mediated fragment 
condensation of Phac-Gly-Trp-Met-OAl and Asp(OMe)-Phe-NH2. In an earlier CCK-5 
synthesis in our laboratory (Xiang, et al., 2004), Phac-Gly-Trp-Met-OEt was first 
converted to the Cam ester by using three chemical steps and was then coupled with 
Asp(OMe)-Phe-NH2. Met-OAl could be used as a nucleophile in the extension of the 
dipetide and was effective enough as an acyl-donor for the 3+2 fragment coupling. With 
this strategy the earlier method has been improved by reducing the number of steps.  
 
The final fragment coupling in the [3+ (3 +2)] approach was successful by coupling Bz-
Arg-Asp(OEt)-Tyr-Met-OAl with Gly-Trp-Met-Asp(OMe)-Phe-NH2. This coupling 
failed when free α-chymotrypsin was used, however, when the enzyme was immobilized 
on Eupergit C, the reaction had 17.1 % product yield. The reason for this quite surprising 
behavior could not be investigated in this work. 
  
As assumed, the cleaving of Bz-Arg from Bz-Arg-Asp(OEt)-Tyr-Met-Gly-Trp-Met- 
Asp(OMe)-Phe-NH2 with trypsin at pH 8.5 was successful and the isolated product was 
pure as can be seen in HPLC (figure 3.14 (b) ). In ESIMS (figure 3.15) there was only 
one significant peak of the target peptide. Therefore there is no doubt, that the 
octapeptide with the free N-terminus was indeed homogeneous. 
 
 
 
 
Summmary 102 
In this thesis it could be demonstrated that the fully enzymatic peptide synthesis even of 
longer peptides is possible if all available condensation methods, coupling in aqueous 
phase, co-solvents, bi-phasic and solvent free conditions are applied. It could also be 
demonstrated that the Bz-Arg group is superior to other used N-terminal protecting 
groups in CCK-8 syntheses, because it can be cleaved easily with trypsin. The enzymatic 
technology, the "Green Chemistry" is a versatile alternative to the chemical peptide 
synthesis. 
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7 Appendix 
 
FABMS spectra 
(1) Fmoc-Gly-OPfp, [M+H+]=464.0 
 
(2) Fmoc-Trp-Opfp, [M+H+]=593.0  
 
 
Appendix 110 
(3) Fmoc-Met-OPfp, [M+H+]=537.9, [M+Na+]=599.9 
 
 
(4) Bz-Arg-Asp(OEt)-OH, [M+H+]=422.2, [M+Na+]=444.2 
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(5) Bz-Arg-Asp(OEt)-Tyr-OH, [M+H+]=585.2, [M+Na+]=607.1 
 
 
 
(6) Bz-Arg-Asp(OEt)-(Tyr)n-OH, [M+H+]=748.3, [M+Na+]=770.3 when n=2;   
     [M+H+]=911.5 when n=3 
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(7) Bz-Arg-Asp(OEt)-Tyr-Met-OH, [M+H+]=716.2 
 
 
 
(8) Bz-Arg-Asp(OEt)-Tyr-Met-OAl, [M+H+]=756.2, [M+Na+]=778.1 
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(9) Asp(OEt)-Tyr-Met-OH, [M+H+]=456.1, [M+Na+]=478.0 
 
 
 
(10) Gly-Trp-OMe, [M+H+]=276.2, [M+Na+]=298.0 
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(11) Diketopiperazine obtained from Gly-Trp-OMe, [M+H+]=244.2 
 
 
(12) Phac-Gly-Trp-Met-OAl, [M+H+]=551.2, [M+Na+]= 573.1 
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(13) Phac-Gly-Trp-Met-Asp(OMe)-Phe-NH2, [M+H+]=786.2 
 
 
(14) Gly-Trp-Met-Asp(OMe)-Phe-NH2, [M+H+]=668.2, [M+Na+]=690.2 
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(15) Gly-Trp-Met-Asp-Phe-NH2, [M+Na+]= 676.1 
 
  
(16) Fmoc-Met-Asp(OMe)-Phe-NH2, [M+H+]=647.0, [M+Na+]=669.2 
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(17) Met-Asp(OMe)-Phe-NH2, [M+H+]= 424.9 
 
 
 
(18) Fmoc-Trp-Met-Asp(OMe)-Phe-NH2, [M+H+]=833.2, [M+Na+]=854.8 
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(19) Trp-Met-Asp(OMe)-Phe-NH2, [M+H+]=611.1 
 
 
 
(20) Fmoc-Gly-Trp-Met-Asp(OMe)-Phe-NH2, [M+H+]=890.2 
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(21)   
HN CH
CH2
O
O
N CH
CH2Ph
CONH2
Trp-Met-
              [M+H+]=579.2, [M+Na+]=601.2             
                 
 
   (22)                                                                                    
              
HN CH
CH2
O
O
N CH
CH2Ph
CONH2
Gly-Trp-Met-
           [M+H+]=636.2, [M+Na+]=658.2 
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 ESIMS 
(1) Bz-Arg-Asp(OEt)-Tyr-Met-Gly-Trp-Met-Asp(OMe)-Phe-NH2, [M+H+]=1365.4 
 
 
 
(2) Asp(OEt)-Tyr-Met-Gly-Trp-Met-Asp(OMe)-Phe-NH2, [M+H+]=1105.2,         
      [M+Na+]=1127 
 
165.0 358.2 423.1
467.2
511.2 555.2
1105.2
+MS, 0.5min (#36)
0.0
0.5
1.0
1.5
2.0
7x10
200 400 600 800 1000 1200 1400 m/z
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